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Abstract 
The effect of a non-steroidal anti-inflammatory  
drug on subclinical endometritis  
and the identification of at-risk cows 
 
by 
Nicola Priest 
 
Subclinical endometritis (SCE) is a uterine pathology characterised by an increased proportion of 
polymorphonuclear cells (PMN) in the uterus after calving, and it is known that SCE has negative 
effects on dairy cow reproductive performance. However, the mechanism by which SCE affects 
reproductive performance in New Zealand dairy cows appears to be different from that reported in 
international literature. This provided the basis for the research reported herein, which sought to 
investigate the mechanism by which SCE reduces reproductive performance of New Zealand dairy 
cows. Furthermore, the need for a practical method to detect or diagnose SCE was identified. 
The objective of the first experiment was to determine if the inflammation associated with SCE, both 
uterine and systemic, is a part of the mechanism by which reproductive performance is reduced in 
cows with this disease. The hypothesis was that reducing this inflammation with a non-steroidal anti-
inflammatory drug (NSAID) would reduce the severity of uterine inflammation (average PMN %), and 
improve reproductive performance. Dairy cows (n = 213) were paired by calving date and day 14 
uterine PMN %, and randomly assigned to either the NSAID treatment (administered 21 - 31 days 
postpartum) or control group. Cows with ≥ 14% PMN in the cytological sample collected at day 14 
postpartum were defined as having SCE. Treatment with a NSAID increased pregnancy rate in SCE 
cows and reduced metabolic indicators of systemic inflammation. There was, however, no effect of 
NSAID treatment on day 42 PMN %, postpartum anovulatory interval, or milk production. Further 
research is required to determine the effect of NSAID on SCE, and evaluate the influence of timing of 
drug application on treatment effectiveness. 
The objective of the second experiment was to determine whether a model could be developed, 
based on known associations between SCE and serum metabolites and cow body condition score, to 
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both predict cows at risk of SCE and reduce the number of cows to be submitted for cytological 
examination to a manageable level. Models were developed based on either a single week’s data 
(week relative to calving; -4, -3, -1, +1, +2), or the herd’s planned start of calving date (27th June, and 
a week later; 4th July). The optimum PMN % threshold was determined for the model with the 
highest predictive value (R2; week +1). The optimum PMN % threshold for the week +1 model’s fitted 
values was 10.7% (sensitivity = 58%, specificity = 81%). This threshold, and all other thresholds 
investigated, however, resulted in combinations of sensitivity and specificity where either too few 
SCE cows were identified, or too many cows would be submitted for cytological examination. These 
results indicate that although a model was generated that could predict all SCE cows, the dual aim of 
predicting cows at-risk and enabling only a subset of cows to be submitted for cytological 
examination was unable to be achieved with the serum and physical parameters evaluated. Further 
research into the aetiology of SCE may provide better biological markers to use for prediction of SCE. 
 
Keywords: subclinical endometritis, anti-inflammatory, reproduction, prediction, serum metabolites, 
body condition score, dairy cow 
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Chapter 1 
Introduction 
New Zealand’s dairy industry is a major contributor to the New Zealand economy as it is the 
country’s biggest export earner, accounting for more than 25% of national export earnings (Burke 
and Verkerk 2010). As greater than 90% of the milk produced is exported at world market prices 
without subsidies, to remain profitable, tight economic constraints are placed on New Zealand dairy 
farmers (Holmes et al. 2002). To remain profitable within these economic constraints, the cost of 
milk production must be kept down. In New Zealand the cost of production is kept low by the use of 
grazed pasture as the main constituent of dairy cow diets, because pasture grazed in situ is the 
lowest cost feed available (Holmes et al. 2002; Blackwell et al. 2010). Therefore, to maximise pasture 
utilisation, and in turn profitability, the changing herd feed demands need to be synchronised with 
the growth pattern of pasture as pasture growth also varies throughout the year (Figure 1) (Parsons 
1988; Burke and Verkerk 2010). This synchrony between pasture availability and herd feed demand is 
achieved by seasonal calving, where cows calve in spring when herd feed demand is greatest and 
pasture growth is maximal (Holmes et al. 2002; Blackwell et al. 2010). 
 
Figure 1: Representation of annual herd feed demand and pasture supply for a pasture-based 
seasonal calving system. Burke and Verkerk (2010), reproduced with permission from 
Reproduction in Domestic Ruminants 7, 2010, published by the Society of Reproduction 
and Fertility, Nottingham, United Kingdom. 
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In New Zealand, more than 95% of milk produced comes from strictly seasonal calving, grazed 
pasture systems (Blackwell et al. 2010). To maximise the number of days in milk and thus milk 
production, cows must calve every year in a tight calving pattern and have a 365 day inter-calving 
interval (Blackwell et al. 2010). This means that farm productivity is directly related to cow 
reproductive performance. To achieve this 365 day inter-calving interval, cows must conceive by 83 
days after calving (Rhodes et al. 2003). This requires cows to resume cycling, display oestrous 
behaviour, be mated during the early part of the breeding period, and in a seasonal calving system, 
conceive by 83 days after the herd’s planned start of calving irrespective of time postpartum (Rhodes 
et al. 2003; Blackwell et al. 2010). Cows that cannot maintain this 365 day inter-calving interval are at 
risk of being culled (Blackwell et al. 2010). 
The New Zealand dairy industry has set targets to achieve optimal reproductive performance. These 
targets are a78% 6-week in-calf rate (78% of the cows pregnant after 6 weeks of mating), 90% 3-
week submission rate (90% of cows mated within the first 3 weeks of the mating period), 60% 
conception rate, and 6% not-in-calf rate after 12 weeks of mating (6% of cows not pregnant by the 
end of the mating period; empty rate) (Burke et al. 2007). However, at an industry level, these 
targets are not being met; in fact herd reproductive performance has been declining (Harris et al. 
2006). The reduction in reproductive performance is partially attributed to the increase in the 
number of cows that are anoestrous at the start of the mating period (Verkerk et al. 2000). This 
increase in the number of anoestrous cows has a 2-fold impact on reproductive performance, in that 
both the 3-week submission rate and the conception rate would be negatively affected. The 3-week 
submission rate would be reduced because there would be fewer cows cycling and thus submitted 
for mating within the first 3 weeks of the mating period. The conception rate would be reduced 
because fertility increases as the number of oestrous cycles postpartum increases (up to ~4 cycles) 
(Thatcher and Wilcox 1973), therefore, the cows that were anoestrous at the start of the mating 
period will not have cycled four times prior to mating, and will therefore have reduced conception 
rates. The reduction in submission and conception rates may result in these cows being culled for not 
getting in calf, or for being a late calver in the current season or the subsequent season. 
The increased risk of culling as a result of being anoestrous at the start of the mating period 
highlights the fact that cows need to calve in the early part of the calving season and resume cycling 
as early postpartum as possible. One factor that can delay the resumption of oestrous activity, and 
negatively affect subsequent conception and pregnancy rates, is uterine disease. The uterine disease 
that is investigated in this thesis, as a part of a larger programme of work, is subclinical endometritis 
(SCE). Subclinical endometritis is a uterine pathology characterised by an increased proportion of 
polymorphonuclear cells (PMN) present in the uterus after calving. International literature has 
identified this disease as a factor that reduces reproductive performance; however, as there was a 
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knowledge gap in the New Zealand context around this disease, the impact of SCE on dairy cow 
reproductive performance in New Zealand was investigated. Previous studies by Burke et al. (2010) 
and McDougall et al. (2011) reported that this disease was present in New Zealand and that it was 
reducing reproductive performance. However, the mechanism by which SCE affected reproductive 
performance in New Zealand dairy cows appeared to be different from that reported in the 
international literature. This has provided the basis for the research reported in this thesis, which 
sought to investigate the mechanism by which SCE reduces reproductive performance in New 
Zealand dairy cows. 
In addition to the need for further research into how SCE is reducing reproductive performance, the 
need for a practical method to detect and diagnose SCE has also been identified. In New Zealand, it is 
common practice for farmers to check their herd for clinical endometritis (Burke et al. 2007). They 
are able to do this using the MetricheckTM device. However, the MetricheckTM device cannot detect 
SCE (McDougall et al. 2011), therefore, currently there is no practical and cost-effective method for 
on-farm detection and diagnosis of SCE. This has led to the investigation of using biological markers 
in serum and cow body condition score to predict cows at risk of SCE. 
The objectives of the research reported in this thesis are two-fold: (1) to attempt to determine if the 
inflammation associated with SCE (both uterine and systemic) is the mechanism by which 
reproductive performance is reduced in cows with SCE, and (2) to validate the usefulness of 
biological markers in serum and cow body condition score for the identification of cows at risk of 
SCE. The specific hypotheses for the research reported in this thesis are: (1) that treatment with non-
steroidal anti-inflammatory drug (NSAID) between 21 and 31 days postpartum will reduce the 
severity (average polymorphonuclear cell (PMN) %) of uterine pathology at 42 days postpartum, 
without lengthening the postpartum anoestrous interval (PPAI), and will mitigate the negative 
association of SCE on reproduction and milk production by reducing inflammation and improving 
liver function, and (2) that metabolic and physical characteristics could be used to predict cows at 
risk of SCE and enable the identification of a subset of cows for cytological examination or 
precautionary treatment. 
 4 
Chapter 2 
Literature review 
2.1 Introduction 
As explained in the previous section, the research described in this thesis was designed to test two 
different hypotheses. Because of this, the literature review covers two essentially separate, but 
related, subjects: i.e. postpartum uterine disease and validation of biological markers. The topics that 
are reviewed in the postpartum uterine diseases section are: endometritis (specifically SCE), its 
prevalence, the effect of this disease on reproductive performance and milk production, the 
proposed mechanisms of how factors associated with SCE reduce reproductive performance, and the 
various treatment options that have been investigated for SCE. In the validation of biological markers 
section, investigations of markers that have been trialled to detect/diagnose SCE are discussed. 
2.2 Postpartum uterine diseases 
Uterine disease can occur in the early postpartum period and manifests as conditions such as 
metritis, pyrometra, or endometritis. An infection of the uterus within the first two weeks after 
calving is called metritis (Sheldon et al. 2006). Metritis involves inflammation in all the layers of the 
uterus: endometrial mucosa and submucosa, muscularis, and serosa (Bondurant 1999). Cows with 
metritis show signs of systemic illness, e.g. fever, depression, weakness, inappetence, and decreased 
milk yields (Bondurant 1999; Sheldon et al. 2006). Pyrometra is a chronic infection of the uterus, with 
accumulation of purulent or mucopurulent material in the uterine lumen in the presence of a corpus 
luteum (CL) (Sheldon et al. 2006; Parkinson et al. 2007). 
Endometritis is defined as superficial inflammation of the endometrium, extending no deeper than 
the stratum spongiosum (Bondurant 1999), that occurs more than two to three weeks postpartum 
(Sheldon et al. 2006; LeBlanc 2008). The reason for stipulating a time frame for this disease is that 
during the two to three weeks immediately after calving, a cow’s uterus undergoes an involution 
process involving tissue remodelling and inflammation. The reported time to gross uterine and 
cervical involution varies greatly from 25 to 47 days in milk (LeBlanc 2008). Thus it is inflammation of 
the uterus that extends beyond two to three weeks postpartum that is termed endometritis (Sheldon 
et al. 2006). Endometritis can be classified as either clinical or subclinical. 
2.2.1 Clinical endometritis 
Clinical endometritis in cows is defined as inflammation and infection of the uterus more than two to 
three weeks postpartum without systemic signs of illness. Affected cows exhibit visual signs such as 
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purulent material on the tail and/or vulva, purulent (21 days postpartum) or mucopurulent (26 days 
postpartum) material accumulated in the vagina, a cervical diameter > 7.5 cm after 20 days 
postpartum, and malodorous mucus (LeBlanc et al. 2002a; Barlund et al. 2008; McDougall et al. 
2011). It must be noted that the criteria for diagnosis, e.g. cervix size, changes with increasing time 
postpartum (LeBlanc et al. 2002a). 
Endometritis, both clinical and subclinical, causes significant economic losses because of decreased 
reproductive performance and reduced milk yield (discussed in later sections), and increased culling 
(Pleticha and Heuwieser 2009), therefore it is a condition that needs to be addressed. Clinical 
endometritis is easy to detect and it is common practice for whole herds to be routinely checked 
with the MetricheckTM device (Burke et al. 2007); therefore cows with clinical endometritis will most 
likely be detected and treated. However, SCE is not easy to detect, which, therefore, means it can go 
untreated, resulting in a greater probability of poor reproductive performance for the affected cows. 
It is for this reason that the research reported in this thesis, where possible, is focused on SCE. 
2.2.2 Subclinical endometritis 
Subclinical endometritis is defined as cows with no systemic signs of illness or clinical infection 
(Barlund et al. 2008), but that have inflammation of the endometrium, which is characterised by an 
elevated population of PMN present in the uterus postpartum (Sheldon et al. 2009). Subclinical 
endometritis has also been described as ‘cytological endometritis’ (Gilbert et al. 2005; Dubuc et al. 
2010). Dubuc et al. (2010) defined cytological endometritis as “an increased proportion of PMN in 
endometrial cytology samples obtained by endometrial cytobrush or low-volume uterine lavage”. 
The authors indicated that cytological/subclinical endometritis and clinical endometritis may actually 
represent different manifestations of reproductive tract disease and inflammation, rather than a 
difference in severity of the same disease. Cows in the Dubuc et al. study were classified as having 
cytological endometritis only, clinical endometritis only, or both cytological and clinical endometritis. 
The results demonstrated that cytological endometritis only and clinical endometritis only had similar 
detrimental effects on reproductive performance. However, for cows that had concurrent cytological 
and clinical endometritis, the detrimental effects of both conditions were additive (Figure 2). This 
finding is important as it may have implications for the way either form of endometritis is detected 
and treated. 
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Figure 2: The effect of cytological endometritis, clinical endometritis, or both, on the proportion of 
cows pregnant. Dubuc et al. (2010), reproduced with permission from Elsevier. 
As mentioned above, SCE is superficial inflammation of the endometrium (Sheldon et al. 2006; 
LeBlanc 2008). The inflammation is present because inflammation is, as part of the innate immune 
system, the body’s response to injury or infection (Serhan et al. 2010). Some of the processes that 
occur during an inflammatory event include recognition of an injury or a foreign invading particle 
(antigen), activation of endothelial cells to release pro-inflammatory cytokines and chemokines, 
influx of polymorphonuclear cells (in particular neutrophils) to the site of the injury/antigen via 
chemotaxis in response to the cytokines and chemokines, stimulation of release of acute-phase 
proteins from the liver in response to proinflammatory cytokines, and phagocytosis of foreign 
invading particles by PMN (Hussain 1989; Sheldon et al. 2009; Serhan et al. 2010; Galvão et al. 2011). 
Inflammation is induced by prostaglandins that stimulate the release of cytokines (Bos et al. 2004). 
Prostaglandins are bioactive lipids that are derived from the conversion of arachidonic acid by the 
cyclooxygenase enzyme (COX) into PGH2 (Figure 3), which is then further metabolised into various 
prostaglandins such as series F, E, I, and D prostaglandins (Mitchell et al. 1993; Sales and Jabbour 
2003; Drillich et al. 2007). The COX-1 enzyme is constitutively expressed in cells; COX-2 is not, but its 
expression is induced by some cytokines, endotoxins and inflammation (Mitchell et al. 1993; Drillich 
et al. 2007). 
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Figure 3: The production of prostaglandins (PGE2, PGF2α, PGI2, PGD2) via the conversion of 
arachidonic acid by the cyclooxygenase enzyme (COX) -1 and -2 (Sordillo et al. 2009). 
In the case of bacterial infection, an inflammatory response is elicited by bacteria infecting the 
uterine endometrium (Galvão et al. 2011). Once a pathogen has come into contact with the 
endometrium, the endometrium is stimulated to produce cytokines and chemokines that attract 
immune cells, in particular PMN, into the uterus and activate these cells once they are there (Galvão 
et al. 2011). There are three kinds of PMN: neutrophils, eosinophils and basophils (Table 1). 
Neutrophils are the main PMN involved in uterine inflammation (Barlund et al. 2008). Neutrophils 
are adept at seeking out and ingesting (phagocytising) bacteria and dead cells (Solomon et al. 2004). 
Most of the cytoplasmic granules in neutrophils contain enzymes that digest the ingested material 
(Solomon et al. 2004; Serhan et al. 2010). 
Table 1: The three types of polymorphonuclear cells1 
Cell type Diagram Main targets Granules Lifespan 
Neutrophil 
 
Bacteria and Fungi 
Fine, faintly pink 
(H & E Stain) 
6 hours – few days 
(days in spleen and other 
tissues) 
Eosinophil 
 
Larger parasites 
Modulate allergic 
inflammatory 
responses 
Pink-orange  
(H & E stain) 
8 – 12 days (circulate for 
4 – 5 hours) 
Basophil 
 
Release histamine for 
inflammatory 
responses 
Large blue A few hours to a few days 
1(Alberts et al. 2007; Serhan et al. 2010) 
The main function of PMN is phagocytosis and killing of invading bacteria. This involves four stages: 
chemotaxis, adherence and attachment, ingestion, and digestion (Hussain 1989). Chemotaxis is the 
Arachidonic acid 
COX 1 and 2 
PGE
2
 
PGF
2α
 
PGI
2
 
PGD
2
 
Pro-inflammatory Resolving 
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directed movement of a cell towards or away from a chemical source (Hussain 1989). When PMN are 
exposed to cytokines and chemokines, the PMN become polarised and move towards the invading 
bacteria (Hussain 1989; Galvão et al. 2011). It appears that the main cytokine involved in recruiting 
PMN into the uterus is interleukin 8 (Ghasemi et al. 2012). Ghasemi et al. (2012) reported that cows 
with SCE had a 50-fold higher gene expression of interleukin 8 than cows without SCE. Once at the 
site of infection, PMN attach to and ingest each bacterium by enclosing it in a phagosome (Hussain 
1989). The bacteria are digested within phagosomes by lysosomal enzymes that are contained in the 
cytoplasmic granules (Hussain 1989). It is because of these cytoplasmic granules that PMN are also 
known as granulocytes. Polymorphonuclear cells are of particular interest with respect to SCE 
because PMN are used to diagnose SCE. 
2.3 Diagnosis of subclinical endometritis 
Subclinical endometritis is diagnosed by determining the proportion of cells that are PMN within an 
uterine cytology sample, i.e. PMN % (Sheldon et al. 2009). Uterine cytology is the collection and 
counting of cells obtained from the uterus, and has become the standard to which other techniques 
are compared (Barlund et al. 2008; Dubuc et al. 2010). There are two cytological techniques 
commonly used to diagnose SCE (Kasimanickam et al. 2005a), the cytobrush method and the uterine 
flushing/lavage method. Briefly, the cytobrush method involves a cytobrush being passed through 
the cervix and gently rotated against the endometrium; the cellular material is then rolled on a slide 
for microscopic evaluation to determine the proportion of cells that are PMN within the sample 
(Kasimanickam et al. 2004; Barlund et al. 2008; McDougall et al. 2009). Uterine flushing involves the 
uterine lumen being flushed with a small volume of saline solution, which is recovered and examined 
by microscopy for the proportion of cells that are PMN within the sample (Gilbert et al. 2005). 
Kasimanickam et al. (2005a) concluded that the cytobrush technique is a more consistent and 
reliable technique than uterine lavage, the latter having a 17% failure rate in retrieving samples, a 
reduced number of PMN recovered, and greater distortion of the recovered cells. For this reason, the 
cytobrush technique will be used for the research conducted in this thesis. 
To determine whether a cow has SCE or not, a diagnostic threshold for PMN % must be set. The PMN 
% threshold used to define cows as having SCE varies depending on the time postpartum that the 
cytology sample was collected and the outcomes being investigated. In general, the PMN % threshold 
used decreases as time postpartum increases (Kasimanickam et al. 2005a; Gabler et al. 2010). This is 
because uterine inflammation decreases as time postpartum increases as a result of the progression 
of the involution process towards completion (Gilbert et al. 2005; Senosy et al. 2009). Studies have 
used different approaches to determine what PMN threshold to use, such as using a PMN % that was 
associated with a negative impact on reproductive performance or grouping cows into quartiles 
based on PMN %. Kasimanickam et al. (2004) used the first approach. The authors used survival 
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analysis to determine the lowest PMN % that was associated with a negative effect on reproductive 
performance; it was determined that > 18% PMN at 20 to 33 days postpartum and > 10% PMN at 34 
to 47 days postpartum defined a cow as having SCE. Burke et al. (2010) used the second approach, 
where the PMN % threshold was determined by categorising the cows into quartiles; the highest 
PMN % quartile (> 6% PMN at day 42 postpartum) was used to identify cows with SCE. Both 
approaches have positives and negatives. The first approach is good in that it determines its PMN % 
threshold based on a tangible outcome, e.g. pregnant or not by a specified time after the start of the 
mating period, rather than using an arbitrary cut-off. However, as many factors other than PMN %, 
such as time from calving to mating and breeding management (Barlund et al. 2008; LeBlanc 2008), 
will influence whether a cow gets pregnant by the specified time, a threshold based on reproductive 
parameters may only be relevant for that specific study population. The benefit of the second 
approach is that it avoids the circular argument of determining a threshold based on the 
reproductive performance of the study population and then using that threshold to assess the 
reproductive performance of that population (McDougall et al. 2011), but there is the potential that 
the upper quartile PMN % may not be associated with reproductive performance at all. Therefore, 
both approaches have merit, but which approach is best will be determined by the research question 
that is being investigated. 
Polymorphonuclear cells are used to diagnose SCE because they are a good indicator of the stage and 
the degree of uterine inflammation as they are the predominant inflammatory cells found in 
intrauterine fluid accumulations (Barlund et al. 2008). Anderson et al. (1985) and Kluciński et al. 
(1990) indicated that there is almost a doubling (~90%) in the number of PMN present in the uterus 
during clinical and subclinical uterine infection. These cells are a part of the body’s innate immune 
system and provide the first line of defence against invading pathogenic organisms (Paape et al. 
2002). Thus, when uterine infection or damage occurs, there is an influx of PMN into the uterine 
lumen (Kasimanickam et al. 2004). 
2.4 Risk factors for endometritis 
The main risk factors for the establishment of uterine infection and inflammation can be grouped 
into four broad categories: reproductive tract damage, metabolic conditions, bacteria, and other 
factors (Table 2). The most common risk factors reported are those associated with calving. Cows 
that experience a difficult calving are at risk of developing endometritis postpartum. This is because 
physical barriers such as the cervix, vagina, and vulva, which are the first line of defence against 
bacteria, are breached and may be damaged during parturition (Sheldon and Dobson 2004). This 
provides the opportunity for bacteria to invade and establish infection (Sheldon and Dobson 2004). 
Uterine tissue damage and devitalisation of the constitution of the birth canal can be caused by 
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dystocia and may result in tissue that is more susceptible to bacterial infection (Parkinson et al. 
2007). 
Table 2: Risk factors for the establishment of endometritis1 
 
 
 
 
Reproductive tract 
damage 
Assisted calving  
Twins 
Dystocia 
Retained fetal membranes 
Still birth 
Delayed uterine involution 
Caesarean section 
Premature calving 
Calving stress 
 
Metabolic conditions 
Milk fever 
Ketosis 
Left displaced abomasum 
 
Bacteria 
Type of bacterial flora in the uterine lumen 
Level of bacterial load 
 
 
 
Other factors 
Increasing cow age 
Trauma 
Endotoxin from the gut 
Injuries 
Mammary gland oedema 
Late calving 
Immune response of the cow 
Uterine endocrine environment 
Level of hygiene of the environment 
Delayed ovarian activity 
1 Results collated from: Knutti et al. (2000), McDougall (2001), Sheldon and Dobson (2004), Drackley 
et al. (2005), Drillich et al. (2005), Sheldon et al. (2006), LeBlanc (2008), Trevisi and Bertoni (2008), 
McDougall et al. (2009), Sheldon et al. (2009), Burke et al. (2010), Cheong et al. (2011a), McDougall 
et al. (2011). 
The distinction must be made, however, between contamination and infection, as not all cows that 
have bacteria present in their uterus have an infection (Sheldon et al. 2006). An infection requires 
adherence of pathogenic organisms to the mucosa, colonisation or penetration of the epithelium by 
the bacteria, and/or the release of bacterial toxins that lead to establishment of uterine disease 
(Janeway et al. 2001). The establishment of infection depends on the bacterial load and species, as 
well as the immune response of the cow (Sheldon et al. 2006; Parkinson et al. 2007). 
The bacterial load within the uterus depends on two main factors; level of contamination and species 
of bacteria (Parkinson et al. 2007). Contamination of the uterus with bacteria occurs during calving 
for most cows. However, cows that suffer from peripartum disorders, such as dystocia and retained 
fetal membranes, will have greater levels of contamination (Parkinson et al. 2007) and are at greater 
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risk of SCE. It must be noted though that although many species of bacteria may have entered the 
uterus after calving, only certain species of bacteria are associated with SCE. Five main bacterial 
species have been identified as the most common pathogenic bacteria isolated from the uterus in 
total mixed ration (TMR) -based farm systems: Arcanobacterium pyogenes, Prevotella 
melaninogenica, Escherichia coli, Fusobacterium necrophorum and Proteus spp. (Sheldon and Dobson 
2004; Williams et al. 2007). The most common bacterial species for pasture-based farm systems have 
not been reported. Of these five species, LeBlanc (2008) reported that commonly cows with 
endometritis will have an infection predominated by Escherichia coli in the first week postpartum 
and Arcanobacterium pyogenes in the second week. However, whether the invasion of the uterus by 
these bacterial species results in infection depends on the immune response of the cow. 
The immune response of a cow depends on many factors including her overall health status and 
endocrine environment (Sheldon et al. 2006; Parkinson et al. 2007). A cow with compromised health 
may be at greater risk of infection as she may not be able to mount a sufficient immune response 
(Kasimanickam et al. 2004). Thus, the metabolic conditions and other factors mentioned in Table 2 
could negatively affect a cow’s immune status and immune function, allowing bacteria to create an 
infection. However, it is not only cows showing systemic signs of illness that may be at risk of SCE. It 
has been reported by Green et al. (2009) and Burke et al. (2010) that cows that are retrospectively 
classified as having SCE (based on PMN %) have indications of systemic inflammation and impaired 
liver function. The indicators reported were a lower albumin concentration, a lower albumin:globulin 
ratio, and elevated plasma concentrations of aspartate aminotransferase (ASAT) and glutamate 
dehydrogenase (GDH). This systemic inflammation and impaired liver function may be negatively 
affecting immune function, but this assertion has yet to be tested or reported. The endocrine 
environment exerts its influence on immune function through progesterone and oestrogens. 
Progesterone is immunosuppressive, which impairs the cows’ ability to mount an appropriate 
immune response to bacteria, whereas oestrogens support immune function (Hussain 1989; Lewis 
2003; LeBlanc 2008). This is in part because high oestrogen levels intensify PMN function, whereas 
high progesterone levels inhibit PMN function (Hussain 1989; LeBlanc 2008). The interaction 
between bacterial factors and cow immune function will affect the prevalence of SCE in the herd. 
2.5 Prevalence of subclinical endometritis 
Studies over the past 10 years in both pasture-based and TMR-based dairy systems have reported 
the prevalence of SCE to range from 6.5 to 53% (Table 3). 
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Table 3: The prevalence of subclinical endometritis diagnosed by cytobrush or lavage cytology 
reported in the literature 
1DIM = days in milk 
2Threshold = polymorphonuclear cell (PMN) % cut-off value used for diagnosing subclinical 
endometritis 
3SCE = subclinical endometritis 
From Table 3 it can be seen that the prevalence of SCE, in general, decreases with increasing time 
postpartum. This is because many affected cows recover spontaneously (Gautam et al. 2009; Burke 
et al. 2010). Green et al. (2009) reported a self-cure rate of 73% for cows with SCE. This can occur up 
to four (LeBlanc et al. 2002b) to eight (Bretzlaff 1987) weeks postpartum. The spontaneous 
resolution of endometritis is usually due to oestrus. When a cow ovulates, there is a spike of 
oestrogens which stimulates uterine motility and PMN function, helping to clear uterine infection 
(Hussain 1989; LeBlanc 2008). The high rate of self-cure in cows with endometritis is a factor that 
needs to be taken into account when interpreting any results reported for the treatment of 
endometritis. 
It is important to note that although the inflammation/infection may have been resolved, its negative 
impact on cow performance may still remain. 
DIM1 Threshold2 SCE3 prevalence Study # of cows 
Cytobrush cytology 
18-38 > 5% PMN 38% Plöntzke et al. (2010) 194 (3 herds) 
18-24 > 18% PMN 35% Lopdell et al. (2011) 46 
20-33 > 18% PMN 35.1% Kasimanickam et al. (2004) 228 
21-31 > 18% PMN 13.5% Heidarpour et al. (2012) 90 
21-33 > 8% PMN 21.5% Madoz et al. (2013) 418 (4 herds) 
28-41 > 8% PMN 11.8% Barlund et al. (2008) 221 (8 herds) 
31-38 > 6% PMN 19.3% Dubuc et al. (2010) 1044 (6 herds) 
32-52 > 5% PMN 19% Plöntzke et al. (2010) 194 (3 herds) 
34-47 > 10% PMN 34% Kasimanickam et al. (2004) 228 
34-47 > 6% PMN 16% Madoz et al. (2013) 418 (4 herds) 
35 > 18% PMN 12.4% Kaufmann et al. (2010a) 209 
39-45 > 18% PMN 7% Lopdell et al. (2011) 46 
48-62 > 4% PMN 16% Madoz et al. (2013) 418 (4 herds) 
53-59 > 4% PMN 11.1% Dubuc et al. (2010) 1018 (6 herds) 
Lavage cytology 
25-31 > 25% PMN 51.8% Hammon et al. (2006) 83 
28-41 > 8% PMN 15.8% Barlund et al. (2008) 221 (8 herds) 
31-38 > 8.5% PMN 38.2% Galvão et al. (2009a) 445 (5 herds) 
40-60 > 5% PMN 53% Gilbert et al. (2005) 141 (5 herds) 
46 > 10% PMN 25.9% Cheong et al. (2011a) 812 (39 herds) 
46-52 > 6.5% PMN 37.2% Galvão et al. (2009a) 445 (5 herds) 
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2.6 The effect of subclinical endometritis on milk production 
It was first hypothesised that endometritis would have no effect on milk production. This hypothesis 
was initially supported by the results of Fourichon et al. (1999) who reported no loss of milk 
production in cows with endometritis, and Dubuc et al. (2011) reported no reduction in milk 
production for cows with SCE. However in studies conducted by Burke et al. (2010) and McDougall et 
al. (2011), daily milk yield in cows with SCE was reduced by 0.6 – 1.03 kg/cow/day, and differences in 
milk composition and somatic cell counts were also reported (Table 4). 
Table 4: The impact of endometritis on milk composition and somatic cell count 
Result reported Impact Reference 
Protein percentage     ↓ Green et al. (2009), Burke et al. (2010) 
Fat percentage     ↓ Green et al. (2009) 
Somatic cell count     ↑ Green et al. (2009) 
The exact mechanism and nature of the link between endometritis and reduced milk production is 
yet to be established. Preliminary theories revolve around reduced dry matter intake (DMI) for cows 
with endometritis, which results in reduced milk production (Bertoni et al. 2008). The proposed 
mechanism is that proinflammatory cytokines, which induce the inflammation associated with 
endometritis, induce anorexia which reduces DMI and, therefore, milk production (Johnson and Finck 
2001). This theory was supported by the reduced DMI and milk production observed in cows with 
inflammation or uterine infection (Bell and Roberts 2007; Huzzey et al. 2007; Bertoni et al. 2008). It 
therefore seems plausible that reducing inflammation would increase milk production. Support for 
this hypothesis is provided by a study reported by Trevisi and Bertoni (2008). Half of the cows in the 
study were untreated controls, the other half were treated with acetylsalicylate, an anti-
inflammatory drug, for the first five days postpartum. The treated cows had higher milk production, 
higher peak milk yield (46.3 vs 40.9 kg/day), and reached peak daily milk production earlier (50.5 vs 
57 days in milk) than control cows. These results indicate that the reduction of inflammation in the 
early postpartum period is beneficial to milk production. 
Compared with the inconsistent effect of SCE on milk production, there is substantial evidence that 
SCE has a negative effect on reproductive performance. 
2.7 The effect of subclinical endometritis on reproductive performance 
The aim of reproductive management is to achieve good reproductive performance, specifically that 
cows become pregnant at a biologically optimal time, in an efficient manner, and at an economically 
beneficial interval after calving (LeBlanc et al. 2002a; Sheldon et al. 2006). In the New Zealand 
seasonal calving system, this means cows must conceive by 83 days postpartum to maintain the 
required a 12 month inter-calving interval, which requires the resumption of normal cyclicity within a 
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few weeks after calving (Opsomer et al. 2000; Rhodes et al. 2003). The ability to resume cycling, and 
other reproductive parameters, has been reported to be negatively affected by SCE (Table 5). 
Table 5: The impact of subclinical endometritis on reproductive performance 
Reproductive measure Impact of SCE a Reference b 
Postpartum anovulatory interval Increased 2, 4, 6 
Submission rate Decreased 6 
First service conception rate Decreased 2, 3, 6 
Services per conception Increased 2, 3 
Days open Increased 1, 2, 3 
Overall pregnancy rate Decreased 1, 2, 3, 5, 6 
a SCE = subclinical endometritis 
b Results collated from: 1) Kasimanickam et al. (2004), 2) Gilbert et al. (2005), 3) Barlund et al. (2008), 
4) Burke et al. (2010), 5) Dubuc et al. (2010), 6) McDougall et al. (2011). 
Despite being a subclinical disease, there is comprehensive evidence that SCE has a negative effect 
on reproductive performance (Table 5). These negative effects have been reported in both pasture-
based and TMR-based dairy systems. In a study reported by Gilbert et al. (2005), conducted in a TMR-
based dairy system, cows with SCE had a lower overall pregnancy rate at 300 days postpartum (63% 
vs 89%), reduced probability of first-service conception (11% vs 36%), delayed days to first service 
(median 101 vs 80 days), more services per conception required (median 3 vs 2 services; Figure 4)and 
more median days open (206 vs 118 days), compared with cows without SCE. 
 
Figure 4: The number of services required per conception for cows with and without subclinical 
endometritis. Gilbert et al. (2005), reproduced with permission from Elsevier. 
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In a study reported by McDougall et al. (2011), conducted in a pasture-based dairy system, cows with 
SCE had a lower proportion (0.57 vs 0.97) pregnant overall, decreased pregnancy to first service, and 
took longer to conceive (56.1 vs 32.6 days from the planned start of mating), compared with cows 
without the condition.  
From the studies reported in this section it is clear that SCE has a negative effect on reproductive 
performance; the question is, how? 
2.8 Factors associated with endometritis that impair reproductive 
performance 
The mechanisms by which SCE/endometritis reduces reproductive performance are still being 
elucidated. This is because the interactions among infectious uterine bacteria, the immune system 
and inflammatory response, and ovarian and uterine function are complex and not entirely 
understood. Parts of these complex interactions are summarised in Figure 5, and explored in greater 
detail in subsequent sections. The proposed mechanisms can be grouped into two broad categories: 
those associated with bacteria, and those associated with the inflammation that accompanies SCE. 
 
Figure 5: Mechanisms by which bacteria and inflammation affect reproductive performance in 
cows (modified, with permission, from Sheldon et al. (2009)). (1) Chemokines and 
cytokines induce polymorphonuclear cells (PMN) to leave the blood and enter the uterine 
 
(8) 
(7) 
(1) 
(6) 
(5) 
(4) 
(2) (3) 
GnRH 
LH 
FSH 
Pituitary 
Hypothalamus 
Ovary 
Receptor 
LPS 
Bacteria 
Receptor 
LPS 
Bacteria 
LPS 
PGF PGE 
Epithelium 
Cell stroma Chemokines/cytokines 
Blood vessel 
PMN 
       
 16 
endometrium. (2&3) Bacterial lipopolysaccharide (LPS) inhibits the secretion of 
gonadotrophin releasing hormone (GnRH) and luteinizing hormone (LH), respectively, but 
has no effect on follicle stimulating hormone (FSH). (4) Bacterial LPS binds to a receptor 
on the ovary and suppresses the production of oestradiol. (5&6) Binding of LPS to 
endometrial cells causes these cells to secrete E series prostaglandins (PGE2) instead of 
the F series prostaglandins (PGF2α). (7) Cytokines reduce the mRNA expression for PGE2. 
(8) Cytokines inhibit the secretion of GnRH. 
2.8.1 Bacteria 
Parkinson et al. (2007) reported that > 90% of cows have bacterial contamination of the uterus for 
the first two weeks after calving, with the prevalence decreasing with increasing time postpartum 
(Table 6). 
Table 6: The proportion of cows’ uteri that are contaminated with bacteria during the postpartum 
period1  
Days after calving Contaminated uteri 
1-7 92% 
8-14 96% 
15-21 76% 
22-28 64% 
29-35 30% 
36-42 30% 
43-49 25% 
1Parkinson et al. (2007), reproduced, with permission, from 2007 Proceedings of the Society of Dairy 
Cattle Veterinarians of the New Zealand Veterinary Association, published by VetLearn, Wellington, 
New Zealand. 
It has been widely reported that the invasion of the uterus by infection-causing bacteria has a 
negative impact on reproductive performance. Bacteria exert their impact on reproductive 
performance in a number of ways: by directly damaging the uterine endometrium (Herath et al. 
2007; Williams et al. 2007) which delays uterine involution (McDougall 2001), through bacterial 
lipopolysaccharide (LPS) disruption of follicle development and steroidogenesis which affects 
subsequent ovulation (Herath et al. 2007), through disruption of the hypothalamus or pituitary gland 
secretions (Battaglia et al. 1999), and through stimulation of the endometrium to secrete 
prostaglandin E2 (PGE2) which leads to persistence of the CL (Williams et al. 2007; Sheldon et al. 
2009).  
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Infection of the uterus with bacteria does not disrupt secretion of follicle-stimulating hormone (FSH), 
thus, the first wave of ovarian follicles emerge approximately 10 days after parturition (Macmillan 
1998; Sheldon et al. 2002). However, cows with endometritis have slower growth of dominant 
follicles and lower peripheral plasma oestradiol concentrations, which reduces the likelihood of 
ovulation (Sheldon et al. 2002). Oestrogens are essential for ovarian follicular growth, development 
and function, and have a central role in nurturing the oocyte and ovulation (Schams and Berisha 
2002). The granulosa cells that surround the oocyte produce oestradiol by aromatisation of 
androstenedione derived from the theca cells, under the regulation of FSH (Fortune 1994). Bacteria 
suppress production of oestradiol from the granulosa cells via the LPS molecules they express on 
their surface (Herath et al. 2007). The LPS migrates to the ovary where it binds to the Toll-like 
receptor-4 /CD14/MD-2 receptor complex, that is expressed by granulosa cells, and down-regulates 
the expression of aromatase genes which results in suppression of oestradiol production and failure 
of ovulation (Herath et al. 2007). 
Another way that bacteria potentially disrupt follicle ovulation is by inhibiting the release of 
gonadotrophin-releasing hormone (GnRH) and luteinising hormone (LH) from the hypothalamus and 
the pituitary gland, respectively (Battaglia et al. 1999; Williams et al. 2001; Herath et al. 2009). Prior 
to ovulation, plasma oestradiol concentrations rise; this signals the hypothalamus and the pituitary 
gland to secrete the pre-ovulatory GnRH and LH surges which precede ovulation of the dominant 
follicle (Moenter et al. 1990). However, the signal from oestradiol required for the surges of GnRH 
and LH can be blocked by LPS (Battaglia et al. 1999), thus preventing ovulation. The mechanism by 
which LPS block the oestrogen signal has not been reported. However, as LPS was administered 
intravenously in this study, perhaps the LPS gained accessed the hypothalamus and pituitary to 
supress the surges through the hypophysial portal blood system. It must be noted though, that LPS 
only suppresses the secretion of gonadotrophins if the signal from the oestradiol is blocked before 
the onset of GnRH/LH surge release. Once the surges have begun, LPS has no effect (Battaglia et al. 
1999). 
Once cows have successfully completed their first ovulation after calving, it is common for those with 
uterine infections to have prolonged luteal phases, thus preventing the next ovulation from occurring 
and delaying conception (Opsomer et al. 2000; Williams et al. 2007). If the infection is not cleared 
during the follicular phase and remains during the following dioestrus, the CL becomes persistent 
and has prolonged progesterone secretion (Parkinson et al. 2007). Progesterone suppresses immune 
function and propagates continued infection (Parkinson et al. 2007), further reducing reproductive 
function. Persistence of the CL is due to insufficient secretion of prostaglandin F2α (PGF2α), which is 
required to regress the CL and terminate the luteal phase (Opsomer et al. 2000; Parkinson et al. 
2007; Williams et al. 2007; Herath et al. 2009). Prostaglandin F2α is secreted from oxytocin-stimulated 
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endometrial epithelial cells and is luteolytic, whereas PGE2, which is also secreted by endometrial 
epithelial cells, is luteotrophic (Arosh et al. 2004). Insufficient secretion of PGF2α can be due to LPS 
binding to endometrial cells and stimulating them to secrete PGE2 instead of PGF2α (Herath et al. 
2009). This results in low concentrations of PGF2α and persistence of the CL. 
In contrast to potentiating CL function, Williams et al. (2007) reported reduced luteal function in 
cows with uterine infections. In this study, cows with uterine infections, that had ovulated, had 
smaller corpora lutea and lower peripheral plasma concentrations of progesterone than normal 
fertile animals. Lower levels of progesterone would inhibit conception and the survival of embryos, 
as sufficient concentrations of progesterone are required to maintain pregnancy (McLeod and 
Phillips 1998). The CL of cows with uterine infections were smaller because cows with uterine 
infections ovulate smaller first dominant follicles, which produce smaller CL (Williams et al. 2007; 
LeBlanc 2008). 
While several studies reporting how bacteria negatively affect reproduction have been discussed in 
this section, not all studies investigating the mechanisms by which endometritis affects reproduction 
have found a link with bacteria. In contrast to the results reported in the TMR studies, the results 
reported by McDougall et al. (2011) indicated that the five most common pathogenic bacteria 
isolated from the uterus in TMR-based farm systems (A. pyogenes, P. melaninogenica, E. coli, F. 
necrophorum and Proteus spp.) were not the major contributing factor to the poor reproductive 
performance observed in cows with SCE in New Zealand dairy systems. This contrasting result may be 
due to differences in management practices and environmental conditions. The authors concluded 
that in cows with SCE, uterine inflammation (as measured by PMN %) is more closely related to the 
negative reproductive outcomes associated with SCE than with isolation of bacteria from the uterus. 
This conclusion is also supported by Barański et al. (2012). Therefore, the results reported by 
McDougall et al. (2011) and Barański et al. (2012) suggest that there are inflammatory mechanisms 
which reduce reproductive performance that are not necessarily related directly to bacteria. 
2.8.2 Inflammation 
Inflammation can be considered as a healing process if it is restrained within certain limits (e.g. 
length of time the inflammation remains and the severity of the inflammatory response) but might 
be harmful if those limits are exceeded (Grimble 2001). These limits appear to be exceeded in some 
cows, as uterine inflammation has been reported to disrupt ovarian function, hypothalamic and 
pituitary gland function, and reduce embryo survival. 
The potential disruption of ovarian function by uterine inflammation was reported by Sheldon et al. 
(2002). The authors reported that cows with uterine inflammation had reduced numbers of first and 
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second dominant follicles in the ovary ipsilateral to the previously gravid horn, reduced dominant 
follicle growth rates and decreased oestradiol secretion. The reduced dominant follicle growth rate 
and oestradiol secretion would most likely result in failure of the dominant follicle to ovulate. A 
possible reason for the reduced oestradiol secretion recorded in the Sheldon et al. (2002) study may 
be that the release of proinflammatory cytokines by endometrial cells impairs granulosa cell 
steroidogenesis (Spicer and Alpizar 1994; Sheldon et al. 2009). It has also been postulated that the 
cytokines secreted by the inflamed endometrium are the reason for the reduced peripheral plasma 
progesterone levels of cows with uterine inflammation (Sheldon et al. 2009). This is because bovine 
luteal cells are highly responsive to a range of cytokines (Petroff et al. 2001; Okuda and Sakumoto 
2003; Sheldon et al. 2009). 
Rivest et al. (1993) reported that cytokines disrupted the hypothalamic-pituitary axis. In a study using 
rats, the cytokine interleukin-1ß was reported to exert an effect on the hypothalamic-pituitary axis 
by altering GnRH neuronal activity and inhibiting the release of hypothalamic GnRH. This would 
prevent occurrence of the pre-ovulatory surge of GnRH that is essential for ovulation. 
Uterine inflammation has been shown to have the potential to reduce embryo survival. Cows with 
uterine inflammation have a suboptimal uterine environment for embryo survival, which contributes 
to poor reproductive performance through embryonic loss. In a study conducted by Hill and Gilbert 
(2008) embryos were cultured in media conditioned with the products recovered from either an 
inflamed or a normal cow endometrium. The embryos cultured in inflamed conditioned media had 
reduced blastocyst quality as determined by lower total trophectoderm cell numbers (83.1 vs 99.8 
cells for inflamed vs non-inflamed conditioned media). This reduction in trophectoderm cell numbers 
would be expected to result in reduced embryo viability and conception rate. The authors proposed 
that the reduction in trophectoderm cell numbers could leave the inner-cell mass of the blastocyst 
susceptible to damage from components such as inflammatory cytokines, and affect placental size 
and function. This hypothesis is supported by Soto et al. (2003) who found that tumour necrosis 
factor-α increased blastomere apoptosis and can thus compromised the development of the 
resultant embryo.  
A potential mechanism for the reduction in embryo quality in cows with uterine inflammation/SCE 
was reported by Back et al. (2011). The cows with SCE in the study had increased concentrations of 
histidine, alanine, aspartate, and serine in follicular fluid. Histidine is important in initiation of the 
inflammatory response and can reduce the production of anti-inflammatory molecules; the other 
three amino acids affect the function of cells of the innate immune system (Li et al. 2007). Back et al. 
concluded that these changes in the amino acid profile could potentially result in altered oocyte 
viability - which in turn could reduce embryo quality and survival. 
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Inflammatory responses are mediated by molecules such as PGE2, which regulate the production of 
various cytokines such as tumour necrosis factor-α and interleukin 6 (Bos et al. 2004; Gabler et al. 
2009). In addition to its immunomodulatory role, PGE2 is considered an important factor to prevent 
rejection of the embryo, as it suppresses the immune system to allow the establishment of 
pregnancy by inhibiting lymphocyte production (Low and Hansen 1988; Bos et al. 2004; Herath et al. 
2009). In a study reported by Gabler et al. (2009), uterine mRNA expression of three PGE2 synthases 
and the synthase of another inflammation mediator, prostaglandin D2 (PGD2; an anti-inflammatory 
molecule), were investigated in cows with or without endometritis. The mRNA expression of all 
components investigated differed in cows with endometritis from those without. Specifically, cows 
with endometritis had lower mRNA expression of the cytosolic PGE2 synthase. This reduction in PGE2 
synthase may mean that insufficient concentrations of PGE2 would be secreted, resulting in failure to 
suppress the maternal immune system and thus embryo loss. 
The cause/source of uterine inflammation in the postpartum period has been widely discussed. 
Reported causes of inflammation and pro-inflammatory cytokine release within the cow include: 
metabolic diseases, parasites, trauma, endotoxin from the gut, injuries, mammary gland oedema, 
calving stress, and bacteria (Drackley et al. 2005; Sheldon et al. 2006; Bertoni et al. 2008). It is well 
known that bacterial infection of the uterus induces an inflammatory response in the uterus (Sheldon 
et al. 2006). However, not all cows that have uterine inflammation have bacteria. Uterine 
inflammation detected in the absence of bacteria has been reported by McDougall et al. (2011) and 
Barański et al. (2012), where not all cows with detectable uterine inflammation (PMN %) were 
culture-positive for bacteria. In addition, Sagartz and Hardenbrook (1971) reported that a higher 
proportion of cows that experienced poor reproductive performance had uterine inflammation 
rather than uterine infection. However, it must be noted, that just because bacteria were not able to 
be cultured, it does not mean that there were no bacteria present. 
Although the cause of this uterine inflammation in the absence of bacteria is yet to be determined, 
one hypothesis has been proposed. Sheldon et al. (2009) suggested that the uterine inflammation 
observed without concurrent bacterial presence could be due to the inflammation, as defined by a 
high PMN count, persisting after the bacteria have been cleared. The inflammation may be persisting 
because it has become dis-regulated. This hypothesis is supported by the results reported by Gabler 
et al. (2009). In this study, cows with SCE had reduced mRNA expression of PGE2 and increased 
expression of PGD2. The authors suggested that these changes in the prostaglandin pathway 
indicated a dis-regulation of the PGE2 and/or PGD2 profile. As PGE2 modulates inflammation, a lower 
level of PGE2 synthesis could lead to inflammation being improperly controlled. Therefore perhaps 
this dis-regulation of the prostaglandin pathway could be the cause of the persistent uterine 
inflammation seen in cows with SCE. 
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Whatever the cause/source of the uterine inflammation, the fact that it has a negative impact on 
reproductive performance is what is important. As stated previously, it has been reported that the 
reduced reproductive performance associated with SCE are more closely related to uterine 
inflammation than the presence of bacteria in the uterus. This indication that inflammation rather 
than presence of bacteria is the cause of poor reproductive performance in cows with SCE is also 
supported by the results reported by Bertoni et al. (2008). When the cows in this study were grouped 
according to inflammation indices, not clinical problems, cows with the highest inflammation indices 
had reduced reproductive performance and milk production. The authors suggested that the 
systemic effects of diseases mediated by proinflammatory cytokines (e.g. endometritis) could be a 
common mechanism for reproductive impairment. The conclusion that inflammation may be the 
more important factor in the poor reproductive performance of cows with SCE than bacterial 
presence in the uterus has important implications for how SCE is treated, and indicates that the 
treatment of SCE should focus on eliminating inflammation rather than bacteria. 
2.9 Treatment of endometritis 
Treatment of endometritis has been the subject of considerable discussion, particularly with respect 
to which therapy to use, which cows to treat (LeBlanc et al. 2002b), and when to treat them. The 
treatments used have focused on; eliminating bacteria (antibiotics, proteolytic enzymes and 
disinfectants), eliminating anoestrus by stimulating oestrus (prostaglandin, PGF2α), resumption of 
normal ovarian activity by removing persistent corpora lutea (PGF2α), and reducing inflammation and 
its negative effects on reproductive performance (e.g. use of a NSAID). Treatments for SCE that have 
been investigated include antibiotics (ceftiofur and cephapirin) and prostaglandins (PGF2α and 
cloprostenol). These treatment options, plus proteolytic enzymes and disinfectants, have also been 
investigated for clinical endometritis. 
2.9.1 Antibiotics 
As bacterial infection appears to be one of the causes of endometritis, it seems logical to use 
antibiotics for therapy. However, there are several things to consider. The formulations should: be 
effective against the pathogens present, not inhibit uterine defence mechanisms, be effective in a 
pyogenic environment, leave no milk or meat residue, have an adequate concentration, incorporate 
an adequate number of treatments, and be cost effective (Drillich et al. 2005; Kasimanickam et al. 
2005b). The proposed theory for antimicrobials working is not that they sterilise the uterus, but that 
they reduce the bacterial load to a level where the cows’ natural defences can gain dominance and 
the inflammatory stimulus is reduced (LeBlanc 2008). 
It has been reported by Kasimanickam et al. (2005b) that treatment with a single intrauterine 
administration of cephapirin increased pregnancy rate by 62% for cows with SCE compared with 
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control cows. Cephapirin is a first generation cephalosporin antibiotic that is predominantly active 
against gram-positive organisms and anaerobic bacteria (Kasimanickam et al. 2005b). However, 
several other studies have reported no beneficial effect on reproductive performance or clinical cure 
rate from the use of antibiotics for either clinical or subclinical endometritis (Knutti et al. 2000; 
LeBlanc et al. 2002b; Galvão et al. 2009b; Kaufmann et al. 2010b). These mixed results indicate that 
antibiotics are not entirely effective as a treatment option for endometritis. This may be the due to 
the fact that not all cows with endometritis have bacteria present in the uterus, and/or that the 
presence of bacteria does not necessarily mean that there is an infection.  
2.9.2 Prostaglandins 
The proposed mechanism by which PGF2α (or one of it analogues such as cloprostenol) treatment is 
effective is that PGF2α induces luteolysis in cows with a responsive CL (Knutti et al. 2000; LeBlanc et 
al. 2002b; Kasimanickam et al. 2005b). This is beneficial especially if the luteal phase has been 
prolonged by endometritis as explained earlier. The decrease in progesterone levels would help the 
uterus to clear any infection as progesterone decreases uterine phagocyte function (Hussain 1989; 
Lewis 2003; LeBlanc 2008). Prostaglandins also stimulate uterine motility and induce oestrus, which 
will help to clear out purulent material from the uterus (Lewis 1997; Knutti et al. 2000; Kasimanickam 
et al. 2005b). 
Galvão et al. (2009a) investigated the effect of PGF2α treatment administered at 21, 35 and 49 days 
postpartum on the cure rate of SCE and subsequent reproductive performance. The results 
demonstrated that PGF2α did not affect SCE prevalence or increase pregnancy rate at days 35 or 49 in 
cows with SCE. Interestingly, first service conception rate was increased by the treatment when 
comparing treated versus control cows (irrespective of endometritis status). However, this was 
attributed to an improvement in the cows without SCE. In contrast to the null result reported by 
Galvão et al. (2009a), Kasimanickam et al. (2005b) reported a 63% higher pregnancy rate for cows 
that were treated with cloprostenol at 20 to 33 days in milk (DIM). Mixed results have also been 
reported for the effectiveness of PGF2α as a treatment for clinical endometritis (Knutti et al. 2000; 
LeBlanc et al. 2002b; Kaufmann et al. 2010b). The inconsistent effect of PGF2α treatment may be due 
to therapeutic trials suffering from a lack of negative controls and small numbers resulting in low 
statistical power (LeBlanc et al. 2002b). On the other hand, for this treatment to work, a responsive 
CL is required. Thus, as the first postpartum ovulation may not have occurred for many cows, due to 
endometritis or other factors, not all cows would have a CL present, resulting in fewer potentially 
responsive cows. Therefore, the mixed results obtained from studies investigating both SCE and 
clinical endometritis, and the need for a responsive CL for the treatment to be effective, indicates 
that PGF2α is not an entirely effective treatment option for endometritis. 
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2.9.3 Proteolytic enzymes and disinfectants 
Increasing criticism by the public and political concern about the use of antibiotics and hormones in 
food-producing animals (Drillich et al. 2005) has led to research into other treatment options. 
Disinfectants and proteolytic enzymes are the two options discussed here. The disinfectant 
investigated by Nakao et al. (1988) was 2% polyvinylpyrrolidone–iodine solution. This disinfectant 
was used because it is less irritating than the commonly used disinfectant, Lugol’s solution. However, 
the results demonstrated that the disinfectant had a negative effect on reproductive performance. 
Proteolytic enzymes were investigated as they have previously been used for the intra-mammary 
treatment of mastitis (Drillich et al. 2005). The enzymes used were chymotrypsin, trypsin, and 
papain. These enzymes have fibrinolytic and proteolytic activity in inflamed tissue which is proposed 
to support the cellular defence mechanism by inhibiting growth and survival of micro-organisms 
(Drillich et al. 2005). Drillich et al. (2005) investigated the treatment of cows with endometritis 21 to 
27 DIM with an enzyme salve (containing chymotrypsin, trypsin, and papain). The results did not 
demonstrate any beneficial effect on clinical cure rate or reproductive performance. The results from 
these two studies demonstrate that neither of these two options is an effective treatment option for 
endometritis. 
2.9.4 Non-steroidal anti-inflammatory drugs 
As previously discussed, SCE is inflammation of the uterine endometrium, and this inflammation is 
associated with a negative impact on reproductive performance. In addition, cows with SCE have 
been reported to have indicators of systemic inflammation. Furthermore, Bertoni et al. (2008) 
reported that the results from their study suggest the systemic effects of diseases mediated by pro-
inflammatory cytokines (such as endometritis) could be a mechanism for reproductive impairment 
and reduced milk yield occurring during and after disease. The authors also suggested that emphasis 
should be placed on reducing inflammation during the postpartum period. This has led to the 
hypothesis that reducing the inflammation associated with SCE (both uterine and systemic) will 
improve reproductive performance. 
Inflammation is induced by prostaglandins that stimulate the release of pro-inflammatory cytokines 
(Elliott and Elliott 1997). Therefore, to reduce inflammation the synthesis of prostaglandins needs to 
be inhibited. Non-steroidal anti-inflammatory drugs block the synthesis of prostaglandins (Sales and 
Jabbour 2003), making NSAID a candidate to treat SCE. Prostaglandin synthesis is inhibited by NSAID 
via inhibition of one, or both, of the two isoforms of the cyclooxygenase enzyme, COX-1 and COX-2 
(Anderson 1990). The COX-1 isoform is constitutively expressed and is considered a to be ‘house-
keeping’ enzyme, whereas COX-2 is generally only expressed during inflammatory events (Mitchell et 
al. 1993; Sales and Jabbour 2003). A NSAID may inhibit either COX-1 or COX-2, or both, depending on 
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the selectivity of the NSAID (von Krueger and Heuwieser 2010). The selectivity of NSAID in cattle has 
not been reported yet. 
Unfortunately there have been no studies reported specifically on treating endometritis (either 
clinical or subclinical) with a NSAID; however there are several studies on the use of a NSAID to 
improve reproductive performance. Which NSAID to use, and when to administer it, are the two 
main questions that researchers have investigated. The use of a NSAID post-insemination to improve 
embryo survival has been investigated in three studies (Erdem and Guzeloglu 2010; von Krueger and 
Heuwieser 2010; Heuwieser et al. 2011), and others have investigated the use of a NSAID in the 
period immediately after calving (Trevisi and Bertoni 2008) to reduce the negative effects of 
inflammation on reproductive performance. 
To maintain pregnancy, PGF2α must be prevented from being secreted by the uterus, as it induces 
luteolysis (Erdem and Guzeloglu 2010; von Krueger and Heuwieser 2010). This secretion is stopped 
by the embryo secreting interferon-τ, the maternal pregnancy recognition protein, which reduces the 
oxytocin-dependent pulsatile release of PGF2α (Thatcher et al. 1995; Bazer et al. 1997). This process 
happens between days 14 to 17 after conception (Bazer et al. 1997). A proposed reason for 
embryonic loss is that there may be retardation of the embryo’s development, which could result in 
insufficient interferon-τ being secreted for the pregnancy to be recognised and prevent luteolysis 
(Erdem and Guzeloglu 2010; von Krueger and Heuwieser 2010). Another proposed reason for 
embryonic loss is that manipulation of the reproductive tract (e.g. insemination) causes inflammatory 
processes, such as the release of cytokines and PGF2α, which can induce luteolysis and embryo loss 
(Heuwieser et al. 2011). 
Erdem and Guzeloglu (2010) investigated whether embryo survival/pregnancy rate would be 
improved by inhibiting luteolysis as a result of suppressing the production of PGF2α through use of a 
NSAID. To do this, a single dose of the NSAID meloxicam was administered at day 15 after artificial 
insemination (AI) and the subsequent pregnancy rate recorded. Meloxicam was chosen as it has a 
longer half-life, and therefore longer anti-inflammatory effect, than flunixin meglumine (Erdem and 
Guzeloglu 2010). The authors reported that the treatment had a negative effect on pregnancy rate 
when compared with the pregnancy rate of the control group. A negative effect on pregnancy rate 
was also reported by Heuwieser et al. (2011) in cows treated with either intrauterine carprofen, or 
carprofen administered subcutaneously, at the time of AI. von Krueger and Heuwieser (2010) 
investigated the use of flunixin meglumine or carprofen on first service conception rate. Flunixin 
meglumine was administered in 2 doses on days 14 to 16 after insemination, and carprofen was 
administered in one dose on day 15 after insemination. The authors reported no increase, relative to 
the control group, in conception to first service for either of the treatments. 
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The results from the studies in the previous paragraph indicate that treatment with a NSAID at, or 
near, the time of insemination is not effective for improving reproductive performance. However, 
treatment of inflammation with a NSAID during the early postpartum period has had more success. 
Trevisi and Bertoni (2008) investigated the effect of acetylsalicylate (AS) given in the first five days 
postpartum. The results demonstrated that cows that received AS had a higher first service 
conception rate, required less services per conception, and fewer cows became repeat breeders. The 
study also reported other interesting results: cows with the lowest inflammatory status had the 
highest milk yield and highest fertility indices, the AS treated cows’ milk yield rose faster and 
remained significantly higher until 60 DIM, the AS cows recovered normal liver protein synthesis 
levels quicker, positive acute phase proteins were reduced quicker, and negative acute phase 
proteins increased and returned to normal faster than for control cows. These results indicate that 
treating cows with inflammation with a NSAID in the early postpartum period is an effective option 
for improving reproductive performance. Therefore, it is possible that treating cows with SCE with a 
NSAID in the early postpartum period will be an effective treatment option for the condition. 
2.10 Validating biological markers 
At this point in time, the most common methods for detecting SCE are uterine cytobrush cytology or 
uterine flushing. These methods are effective for diagnosing SCE, but collecting a sample of cells from 
within the uterus for cytological examination is an invasive and time consuming process. This means 
that although these methods are well suited for the use in scientific research, they are simply not 
practical for on-farm diagnosis of SCE. Therefore, more practical methods for detecting and 
diagnosing SCE are required. 
One potential method is the use of farm cow health records. Peripartum disorders such as dystocia, 
twinning, stillbirth and retained placenta predispose cows to uterine infections (McDougall 2001). 
Therefore, the use of farm cow health records from the period around calving could potentially be 
used to identify cows that are at risk of uterine infection. This would reduce the cost of diagnosis by 
reducing the number of cows to be submitted for veterinary assessment (Sheldon et al. 2006). 
However, this method does not give a specific diagnosis, nor capture all affected cows. In a study 
reported by LeBlanc et al. (2002a), over half the cows with endometritis did not have any of the 
peripartum disorders listed above. This means that more specific markers are required to detect SCE. 
The main focus of research into alternative detection and diagnostic methods has been on biological 
markers. There are two different types of biological markers, direct and indirect. A direct marker is a 
marker that is directly associated with the condition that is being investigated, i.e. a factor that is 
either a direct cause or effect of the condition being investigated. For example, a direct marker for 
milk fever is blood calcium concentration (Parkinson et al. 2010). No direct marker for SCE, other 
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than uterine PMN %, is known. An indirect marker is a marker that is not directly associated with 
condition, but is associated with a part of the physiological processes involved with the condition 
being investigated. For example, an indirect marker for inflammation is leukocyte esterase (Couto et 
al. 2012). A range of indirect markers have been investigated for detection and diagnosis of SCE. 
2.10.1 Dry matter intake 
Studies reported by Zamet et al. (1979), Bell and Roberts (2007), and Huzzey et al. (2007) have found 
an association between cows with uterine infection and depressed DMI, possibly due to depressed 
appetite. Thus, biological markers of DMI could be useful for detecting cows at risk of SCE. Markers 
for DMI include non-esterified fatty-acids (NEFA), urea, glucose, and ß-hydroxybutyrate. Differences 
have been reported in these markers, especially increased plasma NEFA concentrations, in cows with 
endometritis in TMR-based dairy systems (Hammon et al. 2006; Kaufmann et al. 2010a), but not in 
pasture-based dairy systems (Burke et al. 2010). Kaufmann et al. (2010a) investigated whether cut 
points associated with SCE could be established for NEFA, ß-hydroxybutyrate, bilirubin, and urea, and 
whether these cut points could be used as predictors of cows with SCE. Cut points associated with 
SCE were able to be established, but the predictive accuracy of these cut points was not satisfactory 
for practical use. The results from the Kaufmann et al. (2010a) study and the difficulties in measuring 
DMI in pasture-grazed dairy cows, means that DMI and markers of DMI are currently not suitable to 
use for the detection of cows with SCE. 
2.10.2 Milk parameters 
Milk composition and yield were investigated by Green et al. (2009) as biological markers of SCE. The 
significant results reported were deceased milk protein and fat % and an increased somatic cell count 
in cows with SCE compared with control cows. The authors suggested the results indicated that lower 
milk fat %, milk protein %, and milk yield in conjunction with an early MetricheckTM examination 
could aid in the detection of SCE. Practically, measuring and tracking milk production to detect SCE is 
feasible. However, the problem with the use of milk production and composition for detection of SCE 
is that many other factors, such as other illnesses, can also impact milk parameters. In addition, the 
effect of SCE on milk production and composition has been variable. Dubuc et al. (2011) found no 
statistically significant differences in milk yield between cows with and without SCE, however other 
studies have reported a negative association between SCE and milk yield (Burke et al. 2010; 
McDougall et al. 2011). Due to the inconsistency of the effect of SCE on milk production and the 
multi-factorial causes for alterations in milk production, is not likely that milk production will be a 
good biological marker for SCE. 
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2.10.3 Markers in serum/blood 
It has been reported by Huzzey et al. (2007), Bertoni et al. (2008), Green et al. (2009), and Burke et 
al. (2010) that there are links between inflammation, liver function, SCE, and reproductive 
performance. Although these links are more likely to be associations than cause and effect, they 
provide potential markers for SCE in blood/serum. 
Bertoni et al. (2008) investigated the link between inflammation, liver function, and fertility by 
evaluating serum indices around parturition. Inflammation was identified by measuring the 
concentration of positive acute phase proteins (+APP) such as haptoglobin and globulin. Liver 
function was assessed by retrospectively classifying the cows into quartiles using a liver activity 
index, which was based on the plasma concentration of negative acute phase proteins (-APP). The 
authors reported that cows with inflammation (higher plasma concentrations of haptoglobin and 
globulin) had a lower liver activity index (reduced production of –APP liver proteins). It was proposed 
by the authors that the drop in –APP was not due to liver damage, rather that it was due to diversion 
of liver protein synthesis to favour +APP. The liver is still producing as many proteins as normal, but it 
is producing more +APP and less –APP’s (Bertoni et al. 2008). This process was termed ‘liver function 
impairment’ by Bertoni et al. (2008). Impairment of liver function was indicated by lower bilirubin 
clearance, a normal function of the liver (Bertoni et al. 2008). This liver function impairment meant 
that the synthesis of the +APP in the liver was up-regulated at the expense of the –APP, resulting in 
lower plasma concentrations of albumin. Albumin is a -APP produced by the liver under normal 
conditions and helps to maintain blood volume and clotting factors (Fleck 1989; Parkinson et al. 
2010). In addition, Bertoni et al. (2008) reported that cows with the lowest liver activity index (low 
concentrations of –APP) had the lowest milk yield and poorest reproductive performance. These 
results demonstrate that indicators of inflammation, the +APP liver proteins, and indicators of liver 
function impairment, the –APP liver proteins, are associated with reproductive performance. This 
indicates that the positive and negative acute phase liver proteins could be used as biological 
markers for identifying cows at risk of poor reproductive performance. 
In addition to being markers for poor reproductive performance, the acute phase proteins have also 
been suggested as markers for uterine infection. Sheldon and Dobson (2004) reported that increased 
concentrations of non-specific markers of inflammation, such as the acute phase proteins, were 
associated with uterine disease and poorer fertility. In a study reported by Huzzey et al. (2009), cows 
with uterine infections had increased plasma haptoglobin. Haptoglobin is a +APP synthesised by the 
liver whose plasma concentrations is elevated during the acute phase response (Fleck 1989; 
McClatchey 2002; Bertoni et al. 2008). Huzzey et al. (2009) proposed that haptoglobin could be a 
biological marker for predicting uterine infection. 
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The link between inflammation, liver function, and endometritis was investigated by Green et al. 
(2009) and Burke et al. (2010). Green et al. (2009) investigated the association between liver proteins 
and SCE diagnosed at day 21 and 42 postpartum. The cows with SCE had lower plasma albumin, and 
lower total protein concentrations. The authors suggested the decreased plasma albumin and total 
protein could be possible biological markers for SCE. In a study conducted by Burke et al. (2010), 
blood samples were analysed for indicators of liver function (albumin and globulin), inflammation 
(haptoglobin, globulin, GDH, ASAT), and mineral status (Ca and Mg). Cows with SCE at day 42 
postpartum (as classified by >6% PMN) had lower plasma albumin concentration, lower albumin to 
globulin ratio, and lower plasma Mg concentration. These cows also had higher plasma GDH and 
ASAT concentrations. Glutamate dehydrogenase is a liver-specific enzyme with a short plasma half-
life, whose presence in serum indicates liver damage, which can occur during an inflammatory event 
(Taylor et al. 2010). Aspartate aminotransferase is an enzyme from the liver whose concentration in 
blood increases 6 – 10 hours after liver damage occurs (Keogh 2011). In contrast to the results 
reported by Huzzey et al. (2007), plasma concentrations of haptoglobin were not elevated in cows 
with SCE. The results of the Green et al. (2009) and Burke et al. (2010) studies support the existence 
of an association between endometritis, inflammation, impaired liver function, and reduced 
reproductive performance. Therefore, measures of inflammation or liver function could be potential 
markers for SCE. 
Other associations between blood indices and SCE include the haematological measures investigated 
by Green et al. (2009). The haematological measures investigated included red blood cell count, 
haematocrit, haemoglobin, white blood cell count, fibrinogen, lymphocytes and neutrophil %. The 
cows with SCE had higher plasma neutrophil concentrations. Green et al. (2009) suggested the 
increased plasma neutrophil concentration could be a possible biological marker for SCE. Other 
potential markers were reported by Lopdell et al. (2011). In this study, cows with SCE had increased 
plasma concentrations of the amino acids serine and aspartate. Both of these amino acids have 
immune and energetic functions, with serine being involved in the regulation of interleukin-2 
production, T-lymphocyte activation and gluconeogenesis (Li et al. 2007; Wu 2009). Aspartate also 
has a role in leukocyte and lymphocyte function (Wu 2009). The results from these two studies 
indicate that plasma neutrophils and amino acids could be potential markers for SCE. 
The results from all the studies discussed above indicate that markers of inflammation such as 
globulin, ASAT, and GDH, could be viable candidates as biological markers for SCE. Subclinical 
endometritis is inflammation of the uterus; therefore it seems logical that biological markers 
associated with inflammation would be viable candidates as biological markers for the detection of 
cows at risk of SCE. Other potential markers could be indicators of liver function impairment (total 
protein and albumin), plasma neutrophils, and amino acids (serine and aspartate). 
 29 
Although collecting a blood sample from a herd of cows for the diagnosis of SCE is not as quick and 
easy as Metrichecking for clinical endometritis, it is a viable option. Factors that need to be taken 
into consideration are the timing of collection of the blood sample, e.g. pre or postpartum, and the 
cost of sample analysis and thus how many metabolites should be analysed. 
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Chapter 3 
The effect of an anti-inflammatory drug on subclinical endometritis 
3.1 Declaration 
The content in this experimental chapter has been published in the Journal of Dairy Science (vol 96, 
issue 7, pages 4323 to 4332) as an paper entitled ‘The responsiveness of subclinical endometritis to a 
non-steroidal anti-inflammatory drug in pasture-grazed dairy cows’ authored by: N. V. Priest, S. 
McDougall, C. R. Burke, J. R. Roche, M. Mitchell, K. L. McLeod, S. L. Greenwood, and S. Meier. 
Excerpts of data presented in this chapter have also been presented in two conference papers: at the 
New Zealand Society of Animal Production (Priest et al. 2012a), and at the Australasian Dairy Science 
Symposium (Priest et al. 2012b). I was involved in all aspects of the experimental data collection and 
collation, interpretation of results, writing of the manuscripts, and some of the statistical analyses. 
Furthermore, all progesterone assays were performed by me. Other analytes were assayed by 
Gribbles Veterinary Pathology Laboratories. The remainder of the statistical analyses were 
completed by Barbara Dow. The writing of this manuscript was completed with contributions from 
my co-authors, and has benefited from the comments and suggestions of anonymous reviewers. 
3.2 Introduction 
Seasonal, pasture-based dairy cows are constrained to a 365-day inter-calving interval, leaving 83 
days from calving to re-establish pregnancy (Rhodes et al. 2003). A rapid restoration of the uterus to 
a reproductively capable state after calving is, therefore, critical. Uterine disease, such as SCE, 
impedes uterine recovery. Subclinical endometritis is a uterine disorder characterized by an 
increased proportion of PMN in the uterus after calving (Barlund et al. 2008; Sheldon et al. 2009; 
Dubuc et al. 2010). Subclinical endometritis has been reported to be a significant problem in both 
pasture-based and TMR-based dairy systems, with incidence ranging from 6 to 53% (Gilbert et al. 
2005; Green et al. 2009). Negative effects of SCE on reproductive performance include a longer PPAI, 
lower first-service conception rate and overall pregnancy rate, and more services per conception 
(Gilbert et al. 2005; Barlund et al. 2008; Burke et al. 2010); lower milk production and altered milk 
composition have also been reported (Green et al. 2009; Burke et al. 2010; McDougall et al. 2011). 
The cause of SCE and mechanistic links to reduced fertility are not well understood. Subclinical 
endometritis may result from bacterial infection, with lipopolysaccharide disruption of the 
hypothalamic-ovarian axis and uterine secretions reducing reproductive performance (Battaglia et al. 
1999; Herath et al. 2007). Recent indications, however, are that PMN %-defined SCE in pasture-
grazed dairy cows is associated with liver dysfunction and systemic inflammation, and that it is the 
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inflammation (as assessed by PMN %) associated with endometritis and not, necessarily, the 
presence of bacteria in the uterus, which is causing the negative impact on reproductive 
performance (Green et al., 2009; Burke et al., 2010; McDougall et al., 2011). A stronger association 
between poor reproductive performance and inflammation in SCE cows, rather than bacteria, was 
also reported by Barański et al. (2012) in a TMR-based dairy system. Indicators of liver dysfunction 
and systemic inflammation reported for SCE cows include a lower albumin: globulin ratio and 
elevated plasma concentrations of ASAT and GDH (Bertoni et al. 2008; Burke et al. 2010). This 
association of SCE with inflammation (both systemic and uterine), rather than uterine bacteria, 
indicates that treatment of SCE may need to focus on reducing inflammation rather than eliminating 
uterine bacteria; a case for the use of a NSAID. This is supported by the lack of a consistent beneficial 
treatment effect of antibiotics (Kasimanickam et al. 2005b; Galvão et al. 2009b) and prostaglandins 
(Kasimanickam et al. 2005b; Galvão et al. 2009a). 
To test the role of local (and systemic) inflammation associated with SCE in reducing reproductive 
performance, a NSAID was used in this study. One pathway through which NSAID reduces 
inflammation is the COX – prostaglandin pathway. The NSAID inhibits the action of COX and prevents 
the secretion of prostaglandin, a pro-inflammatory molecule (Sordillo et al. 2009; Erdem and 
Guzeloglu 2010; Heuwieser et al. 2011). The timing of NSAID treatment is an important 
consideration, however, because prostaglandin-mediated inflammation is a normal part of the 
uterine involution process after calving (Barlund et al. 2008). For this reason, NSAID treatment was 
delayed until 21 days postpartum in the current study. 
It is hypothesised that treatment with NSAID between 21 and 31 DIM will reduce the severity 
(average PMN %) of uterine pathology at 42 days postpartum, without lengthening the PPAI, and will 
mitigate the negative association of SCE on reproduction and milk production, by reducing 
inflammation and improving liver function. Additionally, the effect of the NSAID treatment on 
circulating metabolites and minerals previously reported to be altered in cows with SCE was 
investigated. The objectives of this study were to determine the effect of a NSAID on PMN % and 
associated effects on reproduction, metabolic indicators, and milk production. 
3.3 Materials and methods 
3.3.1 Experimental design 
Multiparous cows (n = 213; 136 Holstein-Friesian and 77 Holstein-Friesian x Jersey) aged 5.4 ± 2.2 
years (± SD) and with a mean liveweight of 445 ± 56.3 kg were enrolled at Scott Farm (DairyNZ; 
37˚47’S, 175˚19’E), Hamilton, between May and October 2011. Primiparous cows were not included 
due to a lack of availability at the research farm. The number of cows required for the NSAID and 
control groups (n =100) to detect (80% power, 5% significance) a 1/3 reduction in PMN % (e.g. a 
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reduction from 15% to 10% PMN) from day 14 to day 42 cytology was calculated using a standard 
deviation of 0.45 (log10 of PMN %; Meier unpublished data) and a detectable difference of 0.18 
(difference between the day 14 and day 42 log10 PMN % counts). Prior approval for animal use was 
obtained from the Ruakura Animal Ethics Committee, Hamilton, New Zealand (No. 12294). 
To ensure that the control and NSAID treatment groups were balanced for PMN %, a uterine cytology 
sample was taken on day 14 to 17 postpartum (day 14 PMN %). Cows were blocked on calving date 
and day 14 PMN % before being randomly allocated to either the control (n = 109) or the NSAID (n = 
104) treatment group. To allow time for involution to proceed unimpeded, the NSAID treatment was 
initiated at 21 to 25 days postpartum. The cows in the NSAID treatment group (Carprieve LA, 
Norbrook NZ Ltd, Auckland, New Zealand: carprofen 50 mg/mL) were given 3 injections (each 
injection 1.4 mg carprofen/kg liveweight; 1 mL carprofen/35 kg liveweight), at intervals of 3 days, 
between 21 and 31 days postpartum. The rationale for this treatment regime was to ensure an 
extended period of coverage since carprofen has a plasma elimination half-life of 45 to 70 hours 
(Ludwig et al. 1989; Norbrook 2011). 
All cows were examined using the MetricheckTM procedure (McDougall et al. 2007) at day 14 and at 
day 42. A MetricheckTM score of ≥ 3 was determined in 22 cows at day 14 and 4 cows at day 42. None 
of these cows received antibiotic treatment and all were included in the analyses. Cows with calving 
difficulty (n = 1), retained fetal membranes (n = 4), or milk fever (n = 12) were included. Cows (n = 2) 
were excluded if they received a systemic antibiotic during the experiment. 
3.3.2 Uterine cytology 
Uterine endometrial cytology samples were collected on day 14 to 17 (day 14 PMN %) and day 42 to 
45 (day 42 PMN %) postpartum as described by Burke et al. (2010). The vulva of the cow was cleaned 
with paper towel, then a double guarded, modified, AI pipette was passed through the cervix and 
into the uterus. A clean stylette with a clean cytology brush attached (Pap endocervical sample 
brush, EBOS Group Ltd., Christchurch, New Zealand) was used to collect a sample from the uterine 
wall. The stylette was then retracted into the AI sheath and all sampling equipment removed from 
the cow. Material recovered was rolled onto a microscope slide and air-dried. The slides were stained 
once completely dry (Diff-Quick, Dade Behring, Newark, Delaware, USA). The slides were examined 
by a veterinary pathologist (IVABS, Massey University, Palmerston North, New Zealand) for 
determination of the proportion of PMN present. Areas of each slide that contained small clusters of 
epithelial cells (5 to 20 per cluster) were preferentially selected and all identifiable nucleated cells 
counted. Based on day 14 PMN % results, cows were retrospectively grouped into quartiles and cows 
in the upper quartile (≥ 14% PMN, High PMN group) were classified as having SCE. Subclinical 
endometritis at day 42 was defined as a PMN of ≥ 7%, based on the results reported by Burke et al. 
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(2010). Cure of SCE from day 14 to day 42 was defined as a cow that had ≥ 14% PMN at day 14 but 
that had < 7% PMN at day 42. The < 7% PMN cut-off was based on Dubuc et al. (2010) reporting that 
a PMN % of < 7 at 32 to 38 postpartum did not have a negative impact on reproductive outcomes. 
3.3.3 Postpartum anovulatory interval 
Progesterone was measured in plasma collected weekly from 3 days postpartum to 54 days 
postpartum using a commercial kit (Progesterone Coat-a-Count, Siemens, Los Angeles, CA). The 
average intra-assay coefficient of variation (CV) for the high control was 8.4% and 14.6% for the low 
control, and the minimum detectable level was 0.08 ng/mL. The average inter-assay CV was 0.5% for 
the high control, and 9.3% for the low control. Progesterone data were used to determine the PPAI, 
which was defined as the interval from calving to the first sample day that plasma progesterone 
concentration was ≥ 1 ng/mL. The PPAI for 43 of 108 control cows and 32 of 103 NSAID cows was > 
54 days as their progesterone concentrations remained < 1 ng/mL throughout the sampling period. 
3.3.4 Breeding management 
The seasonal breeding period was 10 weeks from 20th September to 29th November. The number of 
days since conception was estimated by a veterinarian at the final pregnancy test (12th January 
2012). This was matched with breeding records. For 4 cows, days pregnant were not consistent with 
the breeding records, therefore the estimated days pregnant from the veterinarian was used instead 
of the days pregnant from the breeding records. 
3.3.5 Blood sample collection 
Duplicate venous blood samples were collected weekly from the tail-head into two evacuated blood 
tubes containing sodium heparin or K2EDTA as the anticoagulant (Vaccutainer, Becton & Dickinson, 
New Jersey, USA) for every cow from 28 days before the estimated calving date to 46 to 54 days after 
calving. Additional samples were collected on the day of calving (D 0) and four days postpartum (D 
4). Blood samples were collected at the same time each day relative to milking (pre-a. m. milking for 
weekly, pre-p. m. for D 0 and D 4 samples). After centrifugation at 1835 x g for 15 min at 4˚C, 
duplicate plasma samples were harvested and stored at -20˚C. 
Plasma was submitted to Gribbles Veterinary Pathology Ltd (Hamilton, New Zealand) within 40 days 
of sampling. All assays were colorimetric and performed at 37˚C with a Roche Modular P800 analyser 
(Roche Diagnostics, Indianapolis, IN), using Roche Modular commercial kits. All samples were 
analysed for: albumin (g/L; bromocresol green reaction at pH 4.1), total protein (g/L; Biuret reaction 
method), ASAT (IU/L; catalysing activity of transamination of L-aspartate to oxaloacetate), GDH (IU/L; 
catalysing activity of NADH-dependent conversion of α-ketoglutarate to glutamate), NEFA (mmol/L; 
commercial kit using the acyl Co-A synthase, acyl-Co-A oxidase method, Wako, Osaka, Japan), and 
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Mg (mmol/L; xlidyl blue reaction). Day 0 and D 4 samples were also analysed for Ca (mmol/L; o-
cresolphthalein complexone method) concentrations. The inter-assay and intra-assay CV for all 
assays were < 5% and < 2%, respectively. 
Levels of Se (nmol/L), Zn (μmol/L), urea (mmol/L) and gamma-glutamyl transferase (IU/L) were 
determined by Gribbles in plasma from additional blood samples collected from 20 randomly 
selected cows at 2 to 3 week pre- and postpartum as a measure of herd-level status for these 
minerals and metabolites. 
3.3.6 Milk production 
Individual milk yields (kg/cow per d) were recorded twice daily (ALPRO, DeLaval, Tumba, Sweden). 
Milk protein, fat, and lactose yield were determined weekly (FT120, Foss Electric, Hillerød, Denmark), 
and SCC every second week (Fossomatic, Foss Electric, Hillerød, Denmark), by Fourier-transfer 
infrared spectroscopy. 
3.3.7 Grazing management and body condition scoring 
Cows were maintained as two separate herds, a dry (pre-calving) and a milking herd, until all cows 
were calved. Both herds received a generous allowance of fresh pasture (ryegrass-white clover mix) 
supplemented with maize silage and grass silage. Cow body condition score (BCS; 10 point scale: 
Roche et al. (2004)) was assessed every second week until 1st June, then weekly until the end of the 
experiment. 
3.3.8 Statistical analyses 
Polymorphonuclear cell percentage 
The day 14 and day 42 PMN % were analysed using linear models. Day 14 PMN % was initially 
included as a covariate for day 42 PMN %, but was excluded when not significant. Angular 
transformation of PMN % was performed before analysis; the raw means are presented to aid 
interpretation. 
Associations between PMN % and the variables measured in this study were analysed using three 
PMN % groups calculated from day 14 PMN % results: High (upper 25%, n = 53, PMN ≥ 14%), Medium 
(middle 50%, n = 105, PMN 2 to 13%), and Low (lower 25%, n = 53, PMN ≤ 1%). 
Reproductive measures  
The proportion of cows that ovulated by a specified date postpartum was analysed using generalized 
linear models with a binomial error distribution in GenStat 14 (VSN-International 2011). Breed 
(Holstein-Friesian vs Holstein-Friesian cross), age (3 yr. old vs ≥ 4 yr. old), their interaction, and PMN 
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group (described above) were included in the model as fixed effects. When estimating the effect of 
NSAID treatment, treatment and the interaction of the PMN groups with treatment were also 
included as fixed effects. Cow was included as a random effect. MetricheckTM group (score ≤ 2 vs 
scores ≥ 3) was initially included in the model, but excluded when not significant. The PPAI was 
analysed using a proportional hazards regression to allow for censored data resulting from having 
only a lower bound for PPAI for cows still anovular at the end of the measurement period. For the 
effect of NSAID treatment, cows that had ovulated before treatment were excluded from the 
analyses (n = 20). 
Pregnancy status was determined by the presence or absence of a viable foetus using transrectal 
ultrasonography at the final pregnancy testing on the 12th January 2012. Conception dates were 
assigned to the corresponding insemination date for the AI bred cows. For the naturally mated cows, 
the fetal age was used to calculate conception date. Conception dates were used to calculate the 
proportion pregnant by 6 (6-week in-calf rate) and 10 weeks (10-week in-calf rate) after the planned 
start of mating (start of the seasonal breeding period). Those diagnosed as non-pregnant by 10 
weeks were used to calculate the non-pregnancy rate. The 3-week submission rate and conception 
rate was not calculated as half of the cows were naturally mated for the full 10 weeks of the mating 
period. The association between day 42 PMN % and pregnancy status was not investigated as there 
was only 12 of 213 (8 control, 4 NSAID) cows with SCE (PMN % ≥ 7%) by day 42. Pregnancy rates were 
analysed using generalized linear models with a binomial error distribution. The model included 
breed (Holstein-Friesian vs Holstein-Friesian cross), age (3 yr. old vs ≥ 4 yr. old), their interaction, 
PMN group (described above), and mating (AI vs natural) as fixed effects. When estimating the effect 
of NSAID treatment, treatment and the interaction of the PMN groups with treatment were also 
included as fixed effects. Cow was included as a random effect. MetricheckTM group (score ≤ 2 vs 
scores ≥ 3) was initially included in the model, but excluded when not significant. 
Metabolites, milk production, and body condition score 
The metabolite, milk production, and BCS data were analysed using mixed models. The metabolite 
data were divided into five periods: pre-calving period (-28 to -1 days postpartum), D 0, D 4, pre-
treatment (6 to 19 days postpartum), and treatment (20 to 47 days postpartum). The BCS data were 
divided into three periods: pre-calving period (-28 to -1 day postpartum), pre-treatment (6 to 19 days 
postpartum), and treatment (20 to 47 days postpartum). The milk production data were divided into 
two periods: pre-treatment (1 to 21 days postpartum) and treatment (3 weeks from four days after 
the start of treatment). Metabolite (ASAT, GDH, and NEFA) and somatic cell count data were log10 
transformed prior to analysis; the raw means are presented to aid interpretation. The model for the 
pre-calving and pre-treatment period analyses included breed (Holstein-Friesian vs Holstein-Friesian 
cross), age (3 yr. old vs ≥ 4 yr. old), their interaction, and PMN group (described above) as fixed 
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effects. For the treatment period model, treatment and the interaction of the PMN groups with 
treatment were also included as fixed effects. Cow was included as a random effect. When 
estimating the effect of NSAID treatment, a covariate was also included in the model as pre-
treatment data may be associated with PMN group. The covariate period for the metabolite and BCS 
data was the pre-treatment data. For the milk data, the covariate period was the week prior to 
treatment. In order to estimate the interaction between PMN group with NSAID treatment, without 
the confounding of PMN group and pre-treatment data, the covariate for each variable was 
calculated by using the residuals from a linear model with the pre-treatment data as stated above as 
the dependent variable, and age, breed, PMN group, and their interactions as the fixed effects. No 
covariate was included in analyses when estimating PMN group differences for the treatment period. 
Alternative models using PMN % as a continuous variable in place of the categorical PMN group were 
also tested. These alternative models did not alter any of the statistical outcomes or interpretations, 
and the results from these are not presented. For all analyses, a significant effect was declared at P < 
0.05, and a trend at P < 0.1. 
3.4 Results 
Average day 14 and day 42 PMN % were 9.9% and 1.5%, respectively (Figure 6), with no effect of 
NSAID treatment on day 42 PMN % (1.4% and 1.7% for the control and NSAID groups, respectively; 
SED = 0.5). The SCE cure rate for the control and NSAID group was 92.3% and 96.3%, respectively. 
 
Figure 6: Polymorphonuclear cell (PMN) percentage distribution in uterine cytology samples from 
dairy cows at a) day 14, and b) day 42 postpartum. 
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3.4.1 Reproduction 
The NSAID treatment did not affect postpartum ovulation rates (46% and 56% ovulated by day 45 
postpartum for the control and NSAID groups, respectively; P > 0.15), and there were no interactions 
(P = 0.98) between treatment and PMN group. A trend (P = 0.09) was found for the Low PMN group 
to have a higher proportion of cows ovulated by 28 days postpartum than the Medium or High PMN 
groups, but not at other times (Figure 7). 
 
Figure 7: Association between polymorphonuclear cell (PMN) group and the proportion of cows 
ovulated by a specified day postpartum. The PMN groups are based on uterine cytology 
results from samples collected on day 14 postpartum: Low PMN (≤ 1% PMN); Medium 
PMN (2 to 13% PMN); High PMN (≥ 14% PMN). Ovulation was defined as the first sample 
day postpartum that progesterone concentration was > 1 ng/mL. Raw means and the 
maximum standard error of the difference (Max SED) are presented. † - There was a trend 
(P = 0.09) for the Low PMN group to have a higher proportion of cows ovulated by 28 
days postpartum than the Medium or High PMN groups, but not at other times. 
Pregnancy rates were not different between the control and NSAID treatment groups (P > 0.28), 
however, there was an interaction (P = 0.04) between NSAID treatment and PMN group 4 weeks 
after the planned start of mating and there was a trend for an interaction at week 5 (P = 0.06), 8 (P = 
0.07), 9 and 10 (P = 0.09) (Figure 8). The interaction reflects an increase in pregnancy rate in the High 
PMN group treated with NSAID, but not the Low or Medium PMN groups. No associations were 
determined between PMN category and pregnancy rates (P > 0.24). The 6-week in-calf rate was 63% 
and 70% for the control and NSAID groups, respectively (P = 0.32). The non-pregnancy rate after 10 
weeks of mating was not affected by treatment: 18% for the control group and 20% for the NSAID 
group (P = 0.72). 
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Figure 8: Effect of a non-steroidal anti-inflammatory drug (NSAID) treatment, and the interaction 
with (A) Low, (B) Medium (MED), and (C) High polymorphonuclear cell (PMN) groups, on 
the proportion of cows pregnant by a specified week after the planned start of mating. 
Uterine cytology results from samples collected on day 14 postpartum were used to 
retrospectively create three PMN groups: Low PMN (≤ 1% PMN); Medium PMN (2 to 13% 
PMN); High PMN (≥ 14% PMN). The weekly pregnancy proportions have been calculated 
using the estimated conception date, which was calculated using the final pregnancy test 
results and mating data. There was an interaction (P = 0.04) between NSAID treatment 
and PMN group 4 weeks after the planned start of mating and there was a trend for an 
interaction at week 5 (P = 0.06), 8 (P = 0.07), 9 and 10 (P = 0.09); the interaction reflects 
an increase in pregnancy rate in the High PMN group treated with NSAID, but not the Low 
or Medium PMN groups. 
3.4.2 Metabolites 
Following treatment with NSAID, cows had lower plasma concentration of ASAT (P = 0.04) and GDH 
(P = 0.18) than untreated cows. The NSAID treatment did not affect the plasma concentrations of the 
other metabolites measured (P > 0.27). No interaction was determined between PMN group and 
treatment for the metabolic measures.  
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Plasma albumin concentrations declined pre- (P = 0.08) and postpartum (P < 0.001) and plasma NEFA 
increased (P = 0.03) on the day of calving with increasing PMN % (Figure 9 and Figure 10). The 
albumin: globulin ratio tended (P = 0.07) to be lower in the High PMN group before the NSAID 
treatment. Prevalence of SCE was associated with indicators of liver function, with High PMN cows 
tending (P > 0.12) towards greater ASAT and GDH concentrations in blood than Low PMN cows pre- 
and postpartum. No associations were determined between PMN group and plasma concentrations 
of total protein and Mg at any time point, but plasma calcium concentration tended to be (P = 0.09) 
lower in the High PMN group on the day of calving. 
 
Figure 9: Plasma concentrations of (a) total protein (b) albumin (c) globulin (d) the 
albumin:globulin ratio (e) aspartate aminotransferase (ASAT) and (f) glutamate 
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dehydrogenase (GDH) for the polymorphonuclear cell (PMN) groups based on uterine 
cytology results from samples collected on day 14 postpartum: Low PMN (≤ 1% PMN); 
Medium PMN (2 to 13% PMN); High PMN (≥ 14% PMN). Raw means and the maximum 
standard error of the difference (Max SED) are presented. 
 
Figure 10: Plasma concentrations of (A) NEFA (B) Mg and (C) Ca for the polymorphonuclear cell 
(PMN) groups based on uterine cytology results from samples collected on day 14 
postpartum: Low PMN (≤ 1% PMN); Medium PMN (2 to 13% PMN); High PMN (≥ 14% 
PMN). Raw means and the maximum standard error of the difference (Max SED) are 
presented. 
3.4.3 Milk production and body condition score 
The mean milk production and composition values for the first 6 weeks of lactation were milk yield = 
18.9 kg/day, milk fat = 0.86 kg/day, milk protein = 0.66 kg/day, lactose = 0.93 kg/day, SCC = 66,100 
cells/mL. The NSAID treatment did not affect (P > 0.74) any of the milk production variables 
measured, nor was there an effect on BCS (P = 0.54, NSAID = 4.1, control = 4.1, SED = 0.03). No 
associations were determined between PMN category and any of the milk composition variables 
measured. There was no difference (P = 0.18; SED = 0.52) in milk yield between the Low (18.9 kg/d) 
 41 
and High PMN groups (18.0 kg/d). The High PMN group were thinner (0.2 BCS units) than both the 
Medium and Low PMN groups pre- (P = 0.09; 4.6, 4.8 and 4.8, respectively) and postpartum (P < 0.05; 
4.0, 4.2 and 4.2, respectively). No interactions were detected between PMN group and NSAID 
treatment for BCS. There was a tendency (P = 0.08) for an interaction between PMN group and 
treatment for milk fat, with milk fat decreasing from the Low to High PMN groups in the NSAID 
treated cows (0.87 kg/d, 0.83 kg/day, 0.82 kg/day for the Low, Medium and High PMN groups 
respectively). 
3.5  Discussion 
The objective of this study was to determine if reducing inflammation associated with SCE through 
treatment with a NSAID would reduce the severity (average PMN %) of uterine disease at 42 days 
postpartum, improve reproductive performance and increase milk production in cows with SCE. In 
spite of a lower than expected average day 14 PMN % (9.9 PMN % on day 14 postpartum), coupled 
with a > 90% self-cure rate by day 42 postpartum, some beneficial effects of NSAID were observed on 
indicators of health and reproductive performance of dairy cows in a pasture-grazed, seasonal 
calving system. 
3.5.1 Effect of NSAID on reproduction, metabolic indicators, and milk production 
An interaction was detected between PMN % and NSAID treatment for pregnancy rate 4 to 10 weeks 
after onset of breeding, indicating a beneficial effect of treatment on pregnancy rate in the High 
PMN cows. In addition, treatment with a NSAID appeared to improve liver function, with reductions 
in plasma ASAT and GDH relative to untreated cows; this indicates that the NSAID treatment had 
some of the intended anti-inflammatory effect. These results confirm the efficacy of treatment with 
NSAID in moderately improving liver function in all NSAID treated cows and pregnancy rate in High 
PMN cows. Data also indicate that NSAID treatment had no negative effect on these parameters in 
Low PMN cows.  
There was, however, no effect of NSAID treatment on day 42 PMN %, the proportion of cows 
ovulated by a specified date, PPAI, or milk production. The reason for the lack of treatment effect on 
these variables is not clear. One possible explanation is the lower than expected day 14 PMN % 
(average 9.9%) among the experimental animals, coupled with a high (> 90%) self-cure rate among 
cows defined as having SCE at day 14. This outcome potentially resulted in a lack of statistical power 
to detect a treatment response. Alternatively, sufficient concentrations of carprofen, to effect a 
beneficial reduction of uterine inflammation, may not have reached the uterine tissues due to the 
route of drug administration used (subcutaneous); a more direct method of administration, such as 
intra-uterine application, may produce a different result to that observed in the current study. 
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Another potential reason for the lack of treatment effect may have been because initiation of 
treatment was delayed until 21 days postpartum to avoid the risk of impeding the prostaglandin-
mediated process of uterine involution. However, since the metabolite results indicated that SCE 
cows were experiencing a degree of liver dysfunction even before calving, delaying treatment to 21 
days postpartum may have reduced the potential benefit of treatment on reproduction and milk 
production in High PMN cows. To support this hypothesis, high-yielding, TMR-fed cows treated with 
aspirin (a NSAID) during the first five days postpartum in the Trevisi and Bertoni (2008) study had a 
higher milk production and improved reproductive performance compared with untreated cows. An 
earlier timing of NSAID treatment (i.e. from calving) in pasture-grazing cows may therefore be worthy 
of future investigation.  
3.5.2 Associations between PMN % and reproduction, metabolic indicators, and 
milk production 
The cut-point of ≥ 14% PMN as the definition of SCE in the current study was based on the lowest 
value of the upper quartile. The advantage in using this approach is that numbers of animals assigned 
to PMN groups (Low, Medium and High) are balanced for statistical power; the same approach used 
by Burke et al. (2010). The limitation, however, is that the cut-point is established by the distribution 
of PMN % values within the experimental population, and not by a pre-defined level that is 
necessarily validated as having a significant biological effect. It is therefore possible that SCE as 
defined in this study is of a less severe condition compared with similarly classified animals in other 
reports (Kasimanickam et al. 2004; Barlund et al. 2008; Dubuc et al. 2010). This fact may have limited 
the ability to detect an effect of the NSAID treatment and any interactions between PMN group and 
treatment. There were, however, some significant biological differences relating to the High PMN 
group; a trend for a lower proportion of cows ovulated by day 28 postpartum, lower plasma 
concentrations of albumin and Ca, lower albumin:globulin ratio, elevated concentrations of ASAT, 
GDH and NEFA, and High PMN cows were thinner than cows in the other two PMN categories. The 
indications are that the cut-point used in this study is biologically relevant. 
The associations between PMN group and reproduction and indicators of metabolic/inflammatory 
challenge found in the current study are generally consistent with previous reports in pasture-fed 
dairy cows (Burke et al., 2010; McDougall et al., 2011). These associations indicate a physiological 
dysfunction, including lower body condition, liver dysfunction and greater metabolic challenge, 
during the periparturient period among cows with elevated PMN % in the uterus postpartum. 
The negative association between PMN group and albumin concentrations and the albumin: globulin 
ratio is similar to that reported previously (Green et al. 2009; Burke et al. 2010). Albumin is a liver-
derived negative acute-phase protein (Fleck 1989), and is commonly regarded as a marker of 
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impaired liver function (Bertoni et al. 2008). Together with a tendency for plasma concentrations of 
ASAT and GDH to be higher in the High PMN cows, the indications are that liver dysfunction is a 
characteristic of cows with elevated PMN %. 
Cows in the High PMN group were thinner than cows in the other PMN categories pre- and 
postpartum and had higher plasma NEFA concentrations on the day of calving. Low pre-calving BCS 
has previously been reported as a risk factor for SCE in pasture-grazed cows (McDougall et al. 2011), 
and increased body fat mobilization, as evidenced by elevated NEFA concentrations, was associated 
with lower DMI and an increased risk of metritis (Hammon et al. 2006; Duffield et al. 2009). 
Furthermore, the High PMN group had a lower plasma concentration of Ca on the day of calving; a 
key time that can reveal the extent of hypocalcaemia experienced by a dairy herd (Goff 2008). Low 
Ca during the transition period reduces immune function and is a risk factor for endometritis in TMR-
fed dairy cows (Mateus and da Costa 2002; Kimura et al. 2006). Additionally, cows with reduced liver 
function have lower plasma Ca concentrations compared with unaffected cows (Bertoni et al. 2008). 
Further studies are required to better understand the underlying reasons for the links between SCE 
and indicators of physiological dysfunction in SCE cows pre-calving. 
This study found no statistically significant differences in milk yield between the PMN groups which is 
consistent with the results reported by Dubuc et al. (2011), but is not consistent with other studies in 
both pasture-grazed and TMR-based systems that have reported a negative association between 
PMN % and milk yield (Senosy et al. 2009; Burke et al. 2010; McDougall et al. 2011). The 0.9 kg/day 
reduction in milk yield for the High PMN cows reported in this study is similar to the 1 kg/day and 0.6 
kg/day reduction in milk yield reported by McDougall et al. (2011) and Burke et al. (2010), 
respectively, indicating that a degree of caution is required with this statistical interpretation. 
3.6 Conclusion 
Although NSAID treatment did not affect uterine PMN % at day 42 postpartum or milk production, 
treatment increased pregnancy rates in High PMN cows and improved liver functionality in all cows. 
Results confirm the earlier findings that cows with SCE present with a degree of physiological 
dysfunction during the periparturient period, with particular evidence for liver dysfunction. Further 
studies need to be conducted to elucidate the causes of the pre-calving physiological dysfunction 
associated with SCE and to evaluate the effect of timing of NSAID treatment on milk production and 
reproduction variables. 
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Chapter 4 
Predicting cows at risk of subclinical endometritis 
4.1 Declaration 
The content in this experimental chapter has been submitted (manuscript number JDR3822) to the 
Journal of Dairy Research as a manuscript entitled ‘Peripartum serum metabolites and cow body 
condition are poor predictors of subclinical endometritis in dairy cows’ authored by: N.V. Priest, K. L. 
McLeod, C. R. Burke, S. McDougall, J. R. Roche, M. D. Mitchell, S. L. Greenwood, and S. Meier. I was 
involved in all aspects of the design, execution, and analysis of the research reported in this chapter. 
The writing of this manuscript was completed with contributions from my co-authors, and has 
benefited from the comments and suggestions of anonymous reviewers. 
4.2 Introduction 
Subclinical endometritis is a uterine disease characterised by an increased proportion of PMN 
present in the uterus after calving (Barlund et al. 2008; Sheldon et al. 2009; Dubuc et al. 2010), with 
prevalence ranging from 9 to 55% (LeBlanc 2008; Green et al. 2011). Negative effects of SCE on 
reproduction include increased postpartum anovulatory interval, reduced first-service conception 
rate and overall pregnancy rate, and increased number of services per conception (Gilbert et al. 
2005; Barlund et al. 2008; Burke et al. 2010). Despite the recognised negative effects of SCE on 
reproduction, there is no practical on-farm method to diagnose SCE, and it is, therefore, not routinely 
monitored or managed in commercial herds (Cheong et al. 2011b). 
Under research conditions, SCE is diagnosed by uterine cytology, which involves the collection of cells 
from within the uterus and the manual counting of PMN cells (Kasimanickam et al. 2004; Barlund et 
al. 2008). This method is invasive and time consuming, requires specialist equipment and technical 
expertise (Couto et al. 2012), and is impractical and expensive when examining the whole herd. 
Other more practical methods for SCE diagnosis have been investigated, such as uterine 
ultrasonography or the leukocyte esterase test (Cheong et al. 2011b; Couto et al. 2012; Meira Jr et al. 
2012), but these methods have poor sensitivity and specificity, resulting in either too few cows with 
SCE being detected or too many cows being submitted for cytological examination. Therefore, a 
practical on-farm method is required to diagnose SCE or to reduce the number of cows to be 
submitted for uterine cytology. Such a method should have both high sensitivity and specificity. 
Associations between SCE and various biological markers have been reported including: serum 
metabolites (Burke et al. 2010; Lopdell et al. 2011; Priest et al. 2013), cow BCS (McDougall et al. 
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2011; Priest et al. 2013), cytokine gene expression (Gabler et al. 2009; Galvão et al. 2011; Ghasemi et 
al. 2012), uterine gene expression (Gabler et al. 2009), milk yield and composition (Burke et al. 2010; 
McDougall et al. 2011), and follicular fluid composition (Back et al. 2011). Therefore, it was 
hypothesised that metabolic and physical characteristics could be used to predict cows at risk of SCE 
and enable the identification of a subset of cows for cytological examination or precautionary 
treatment. The objective of this study was to develop a method to predict cows at risk of SCE, based 
on serum metabolites and BCS, and reduce the number of cows to be submitted for cytological 
examination or proactive treatment to a manageable level. 
4.3 Materials and methods 
4.3.1 Dataset 1 
Dataset 1 was obtained from a previous experiment reported by Priest et al. (2013), who used 213 
multiparous Holstein-Friesian and Friesian-Jersey cross dairy cows, grazed on pasture, in an 
investigation of NSAID treatment for reducing inflammation associated with SCE. The study involved 
the collection of uterine samples for cytology at day 14 postpartum as well as weekly blood samples 
from each cow 25 ± 3 days before predicted calving date to 50 ± 4 days after calving. Serum 
harvested from the blood samples were analysed for several parameters including NEFA, albumin, 
globulin, albumin:globulin ratio (AGR), Mg, ASAT and GDH. Body condition score was assessed 
weekly using the 10 point scale described by Roche et al. (2004). 
4.3.2 Dataset 2 
This dataset, used for validation, was obtained from a study (Roche et al. 2013) investigating the 
effect of BCS on cow health during the transition period, in 60 Holstein-Friesian and Friesian-Jersey 
cross dairy cows that had been managed to generate different BCS at calving (3.5, 4.5 and 5.5; 10-
point scale). Cow BCS and blood samples were collected weekly from two weeks prepartum to six 
weeks postpartum, and uterine samples were collected for cytology on day 14 postpartum. Serum 
harvested from the blood samples was analysed for several parameters including NEFA, albumin, 
globulin, AGR, Mg, ASAT, and GDH. 
4.3.3 Data used 
Two approaches were used to generate models from the serum metabolite and BCS data in Dataset 
1. The first approach was to generate models based on week relative to calving, where a single 
week’s data relative to cow calving date were analysed in each model. A single week’s data were 
used because it would be impractical to collect a blood sample at more than one time point from an 
individual cow on a dairy farm. The second approach was to generate models based on the herd 
planned start of calving date. The second approach is a feasible option for farmers because they 
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could sample all cows on one day, rather than on different days in relation to individual cow calving 
date. Models were generated for weeks -4, -3, -2, -1, +1 and +2 relative to calving, and two set dates 
relative to the herd planned start of calving: 27 June (week of planned start of calving), 4 July (the 
week after the planned start of calving). The models using week -4 and -3 data and herd planned 
start of calving options (27 June and 4 July) could not be validated because equivalent, or insufficient, 
data were available in Dataset 2. 
Serum data from the two datasets included a range of metabolites (8 in Dataset 1, and 13 in Dataset 
2) but only 7 parameters were common to both datasets (NEFA, albumin, globulin, AGR, Mg, ASAT 
and GDH), and therefore used to generate the models. The number of cows included in each model 
varied due to missing metabolite data. 
4.3.4 Statistical analyses 
All-subsets regression analysis (GenStat 14.1; VSN-International (2011)) was used to determine which 
metabolites and BCS were to be included in the final model for each week or date for Dataset 1. For 
the all-subsets regression analysis, the percentage of PMN cells in the uterine cytology sample was 
analysed using generalized linear models with a binomial error distribution and the logit link 
function; ASAT, GDH, NEFA, and Mg were log10 transformed prior to analysis. Initially, for each week 
or date, the linear and quadratic terms for each metabolite were included in the model, but the 
quadratic terms were excluded when not significant. Only terms that were significant (P < 0.05) were 
included in the final model for each week or date. The equations from the final models were used to 
calculate the fitted values for PMN % for each week, or date, analysed in Dataset 1 and were also 
used to calculate the predicted values for PMN % for Dataset 2. The fitted and predicted PMN % 
values were back-transformed to aid interpretation and, using simple correlations, the fitted and 
predicted values for each model were compared with actual PMN %, and an R2 obtained. A receiver 
operating characteristic (ROC) curve was plotted using the sensitivity (percentage of at-risk cows 
correctly identified) and specificity (percentage of healthy cows identified as healthy) for every fitted 
PMN % obtained for the model with the highest predictive value (R2). Sensitivity and specificity were 
calculated based on cows at risk of SCE being defined as having > 18% PMN at day 14 postpartum. 
This threshold was based on the reproductive-outcome defined PMN % threshold previously 
reported for uterine cytology examinations conducted around this time postpartum (Kasimanickam 
et al. 2004). The optimum PMN % threshold for the fitted values obtained from the model with the 
highest predictive value was calculated from the ROC curve using the Youden index, which is the 
maximum difference between sensitivity and 1 – specificity (Schisterman and Perkins 2007). 
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4.4 Results and discussion 
The ability to predict the cows at risk of SCE was tested by generating models based on serum 
metabolite and BCS data from Dataset 1 and validating the results with Dataset 2. The results 
indicate that a model based on serum metabolite and BCS data can predict the cows at risk of SCE. 
However, the high percentage of false positives obtained for this model, which would result in 95% 
of the herd still being submitted for cytology, means that the objective of reducing the number of 
cows to be submitted for cytological examination or proactive treatment to a manageable level was 
not achieved. 
Table 7: Regression equations for the models generated to predict polymorphonuclear cell % in 
uterine cytology samples. Models were derived from serum metabolite concentration 
and body condition score data collected from 4 weeks pre to 2 weeks postpartum and at 
two set dates (planned start of calving and one week later). Models names including ‘V’ 
were validated against a separate data set (results reported in the body of the paper), but 
suitable data were not available for validating the remaining equations. 
Model† Equation #cows‡ P-value R2 
Week -1V 1.17 – 0.0965 * albumin 203 0.04 0.01 
Week +1V 3.90 – 0.1739 * albumin + 0.927 * log10 NEFA
 210 <0.001 0.14 
Week +2V 5.45 – 0.0858 * globulin – 4.57 * AGR 211 <0.001 0.10 
Week -4 -3.818 + 1.540 * log10 GDH
 168 <0.001 0.09 
Week -3 1.54 – 0.1084 * albumin 210 0.03 0.03 
27 June -0.730 – 1.806 * AGR 144 0.01 0.04 
4 July -4.00 – 0.1846 * albumin + 0.1143 * globulin + 4.09 * AGR 146 0.04 0.05 
†Each model was generated from either one week’s serum metabolite and body condition score data 
(week relative to calving) or data collected on a date relative to the herd’s planned start of calving 
(planned start of calving and one week later) 
‡#cows = number of cows included in each model 
The significant (P < 0.05) models generated from Dataset 1 are presented in Table 7. No model was 
generated for week -2 as none of the evaluated parameters were significant for this week (P > 0.05). 
There were significant (P < 0.05) correlations between fitted and actual PMN % values for all weeks 
except for week -1 (P = 0.13). Despite the significant correlations, the predictive value of the models 
was relatively poor, with R2 values that ranged from 0.01 to 0.14. The model with the highest 
predictive value was week +1 (R2 = 0.14; Figure 11). The poor predictive value of the models was 
confirmed with Dataset 2. When using the models to predict PMN % for Dataset 2, the only model 
that had a significant (P = 0.05) correlation between the actual and predicted PMN % was week +1, 
and the R2 values for the regression of predicted against actual PMN % ranged from 0.03 to 0.11 
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(Figure 12). The R2 value for week +1 was lower for the correlation between the predicted and actual 
PMN % (R2 = 0.11) than for the correlation between the fitted and actual PMN % (R2 = 0.14). 
 
Figure 11: Regression of actual polymorphonuclear cell (PMN) % values against fitted PMN % for 
the week +1 model. The actual PMN % values were obtained from Dataset 1, and the 
fitted PMN % values were calculated from Dataset 1 using the equation for the week +1 
model. The week +1 model was generated from serum metabolite and cow body 
condition score data collected one week after calving. 
 
Figure 12: Regression of actual polymorphonuclear cell (PMN) % values against predicted PMN % 
for models (week relative to calving): a) week -1, b) week +1, and c) week +2. The actual 
PMN % values were obtained from Dataset 2, and the predicted PMN % values were 
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calculated from Dataset 2 using the Dataset 1 equations. The models were generated 
from a single week’s serum metabolite and cow body condition score data that was 
collected weekly relative to calving. The P-value displayed is for the correlation between 
the actual and predicted PMN % values. 
In addition to the relatively low R2 value, the combinations of sensitivity and specificity obtained for 
the model with the highest predictive value (week +1) were unable to achieve the objectives of the 
study (Figure 13). From the ROC curve and Youden index, the optimum PMN % threshold for the 
fitted values of the week +1 model was 10.7%, which had a sensitivity of 58% and a specificity of 
81%. This sensitivity would result in a high percentage of the affected cows not being identified. In an 
attempt to improve sensitivity, the fitted value threshold for PMN % was reduced to 5%. This 
resulted in an acceptable sensitivity of 100%, but an unacceptably low specificity (7%) would mean 
that 95% of the herd would be submitted for cytology. Furthermore, the sensitivities and specificities 
reported here were less than those reported for the leukocyte esterase test, which has already been 
deemed inaccurate for diagnosing SCE (Cheong et al. 2011b; Couto et al. 2012). Therefore, the results 
indicate that the combination of metabolites and physical parameters considered here cannot be 
used to achieve the dual aim of predicting cows at risk of SCE and enabling only a subset of cows to 
be submitted for cytological examination. 
 
Figure 13: Sensitivity and specificity for predicting cows at risk of subclinical endometritis using five 
polymorphonuclear cell (PMN) % fitted value thresholds obtained from a receiver 
operating characteristic curve. The fitted values for PMN % were calculated from a model 
based on serum metabolite and cow body condition score data obtained one week after 
calving (week +1 model). 
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A possible reason for the unacceptable sensitivity and specificity of the model relates to the markers 
chosen. The markers used were chosen because they are physiological measures that have been 
reported to be associated with SCE (Burke et al. 2010; Lopdell et al. 2011; McDougall et al. 2011; 
Priest et al. 2013). However, these markers are indirect physiological measures at the animal level, 
such as indicators of energy status and liver function, rather than more direct markers of uterine 
inflammation, such as uterine PMN % or uterine cytokine gene expression (Barlund et al. 2008; 
Fischer et al. 2010). In addition, the markers evaluated here will undergo significant changes 
throughout the transition period, for example significant increases in NEFA after calving, which are 
driven by processes not necessarily related to SCE, such as calving stress and homeorhetic processes 
facilitating significant increases in milk production (Drackley et al. 2005). Thus, although the markers 
evaluated here are associated with SCE, there are many other factors that influence their 
concentrations in serum, which challenges their use for predicting the cows at risk of SCE. However, 
the negative impact of SCE on reproductive performance (Gilbert et al. 2005; Barlund et al. 2008; 
Burke et al. 2010) indicates a strong need to identify cows at risk of SCE. Moyes et al. (2013) reported 
that a physiological imbalance index based on pre-calving blood metabolite (NEFA, beta-
hydroxybutyrate, and glucose) concentrations was able to predict the cows at risk of developing 
clinical postpartum diseases such as mastitis, metritis, milk fever, and lameness. This indicates that 
indirect markers, e.g. serum metabolites, can be used to predict clinical postpartum diseases. 
However, although indirect markers could be used to predict cows at risk of clinical disease (Moyes 
et al. 2013), other, or more direct, biological markers may be required for the prediction of 
subclinical diseases, such as SCE. 
4.5 Conclusion 
In conclusion, a model was generated that correctly identified 100% of the cows with SCE, but the 
specificity associated with this model was low. Therefore, the results indicate that a model based on 
the parameters used in this study is unable to achieve the dual aim of predicting cows at risk of SCE 
and enabling only a subset of cows to be submitted for cytological examination. However, the benefit 
of identifying all cows with SCE may outweigh the costs of still having to examine/treat most of the 
herd, so the feasibility of a model based on serum metabolites and BCS on-farm still requires further 
investigation. 
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Chapter 5 
General discussion 
The over-arching hypothesis of the first experiment (Priest et al. 2013) was that the inflammation 
associated with SCE, both uterine and systemic, is a part of the mechanism by which reproductive 
performance is reduced in cows with SCE. To test this hypothesis, cows were treated with a systemic 
NSAID, and the effects of the NSAID treatment on uterine PMN %, reproduction, and milk production 
were measured. In summary, the NSAID treatment did not reduce the severity of uterine pathology 
at day 42 (average PMN %) or mitigate the negative association between SCE and milk production, 
but the treatment did increase pregnancy rate in cows with SCE, and it reduced the concentrations of 
indicators of systemic inflammation and improved liver function in treated cows. This improvement 
in pregnancy rate in the cows with SCE was a positive outcome for the experiment, and the result is 
supported by the improvement in pregnancy rate in acetylsalicylate (a NSAID) treated cows reported 
by Trevisi and Bertoni (2008). One question raised by this result was, what is the mechanism by 
which NSAID treatment improves pregnancy rate in SCE cows? Was the improvement due to (1) a 
reduction in uterine inflammation (measured as uterine PMN %) as a result of the NSAID treatment 
which we were unable to detect in this experiment, (2) the observed reduction in systemic 
inflammation (ASAT and GDH concentrations), or (3) was the improvement due to the NSAID having 
an effect on reproduction through other unidentified pathways? 
5.1 Mechanisms by which reproduction was improved 
For the three scenarios outlined in the previous paragraph, three of the potential pathways by which 
the NSAID treatment improved pregnancy rate in SCE cows are (Figure 14): (1) that the NSAID 
reduced uterine prostaglandin synthesis, which in turn reduced uterine cytokine concentration and 
resulted in the reduction of uterine PMN %, which is the measure used in this experiment to quantify 
the level of uterine inflammation (scenario 1, blue arrows); (2) that the NSAID reduced systemic 
prostaglandin synthesis and thus systemic cytokine concentrations, which had flow on effects 
through two different pathways to the reproductive axis (scenario 2, red arrows); and (3) that the 
NSAID altered the systemic prostaglandin/eicosanoid profiles which may have had beneficial effects 
on the reproductive axis (scenario 3, dashed black and purple arrows). Answering the question of 
how the NSAID treatment increased pregnancy rate in SCE cows is important as the outcome may 
have implications for how SCE is detected and treated in the future. These three scenarios are 
discussed in greater detail below - sections 5.1.1, 5.1.2, and 5.1.3. 
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Figure 14: The potential pathways by which a non-steroidal anti-inflammatory drug (NSAID) 
treatment increased pregnancy rate in cows with subclinical endometritis. The blue 
arrows represent the pathway discussed for scenario 1, the red arrows represent the 
pathways discussed for scenario 2, and the dashed black and purple arrows represent the 
pathways discussed for scenario 3. The box labelled ‘reproductive axis’ represents 
components of the reproductive axis such as the hypothalamus and the ovaries. PMN = 
polymorphonuclear cells. 
5.1.1 Scenario 1 
Uterine cytology samples were collected at days 14 and 42 postpartum to determine uterine PMN % 
and the effect of the NSAID treatment on PMN %. The results demonstrated that there was no 
difference in PMN % between the control and NSAID groups at day 42, and that there was a high self-
cure rate (> 90%) of SCE from day 14 to day 42 postpartum in the control cows. However, due to the 
reasons listed below, it is possible that the NSAID treatment did have an effect on uterine PMN %, 
and therefore uterine inflammation, which was unable to be detected in this experiment. 
 
Prostaglandins Eicosanoids Eicosanoids 
Cytokines 
Syste
m
ic 
U
teru
s 
Prostaglandins 
NSAID 
Cytokines 
Liver function 
Energy balance 
Reproductive axis 
PMN 
Improved pregnancy rate 
Cow body 
 53 
 Samples not being taken (because of logistical constraints) during the time period of 
expected treatment effect (approximately days 21 to 32 postpartum) 
 The long period of time between the uterine samples that were collected 
 The high SCE self-cure rate in the control cows 
In other words, although the change in PMN % from day 14 to day 42 was similar between the 
control and NSAID groups, if samples had been taken between days 14 and 42, they may have shown 
a steeper slope of decline in PMN % in the NSAID treated cows (Figure 15). A faster reduction in PMN 
% and uterine inflammation would mean that the NSAID-treated SCE cows may return to a healthy 
uterine status faster than the untreated (control) cows with SCE, which would be beneficial to their 
reproductive performance. Therefore, a faster reduction of uterine inflammation (PMN %) may have 
been the mechanism by which pregnancy rate was improved in the SCE cows. 
  
Figure 15: Hypothetical example of potential differences in polymorphonuclear cell (PMN) % rate 
of decline from 14 to 42 days postpartum between cows that were treated with a non-
steroidal anti-inflammatory drug (NSAID) and those that were not (Control). The shaded 
area is the period during which the NSAID treatment was administered. 
This potential faster reduction of PMN % could have an implication at the farm system level. As 
discussed in the literature review (Chapter 2, section 2.8.2), Hill and Gilbert (2008) reported that 
embryos cultured in the products of an inflamed endometrium are of poorer quality, which may lead 
to reduced embryo survival. This means that reducing uterine inflammation with a NSAID may be 
beneficial to the pregnancy rate of late calving cows. This is because late calving cows will have had a 
shorter time, compared with early calving cows, from calving to when they are mated in which to 
resolve their uterine inflammation. This shorter interval from calving to mating means that the late 
calving cows could still have some uterine inflammation at the time of breeding, which could reduce 
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their conception and pregnancy rates. If the conception rate of late calving cows were improved, this 
would help to improve a farm’s 6-week in-calf rate, which would increase days in milk and reduce 
culling due to poor reproductive performance (Burke et al. 2007). 
On the other hand, it has never been shown that a systemic NSAID treatment, such as that used in 
the first experiment, actually affects uterine inflammation (PMN %) or the uterine prostaglandin 
profile; it has just always been assumed that it does. Several studies have investigated the use of a 
NSAID to reduce uterine and reproductive tract inflammation around the time of insemination or 
embryo transfer (Guzeloglu et al. 2007; Erdem and Guzeloglu 2010; von Krueger and Heuwieser 
2010; Heuwieser et al. 2011). None of these studies, or any other studies as far as I am aware, have 
tested or reported whether a systemic NSAID (i.e. a NSAID administered s.c. or i.m., not inter-
uterine) actually alters/reduces uterine prostaglandin concentrations, which is the expected 
physiological response to a NSAID, or indeed reduces uterine inflammation (e.g. uterine PMN % or 
cytokine concentrations). Therefore it is just as likely that the NSAID treatment did not affect uterine 
PMN % at all, as the results for this experiment suggest. An experiment needs to be conducted to 
determine whether a systemic NSAID does actually have any effect on uterine prostaglandin and 
therefore uterine inflammation profiles. 
5.1.2 Scenario 2 
The metabolite results indicate that the NSAID treatment reduced the level of systemic inflammation 
(ASAT and GDH concentrations) in all cows treated. It has previously been reported by Bertoni et al. 
(2008) that cows with lower levels of inflammation during the periparturient period have greater 
reproductive performance. In addition, the reduction of inflammation during the early postpartum 
period through the use of a NSAID resulted in higher pregnancy rates in NSAID treated cows (Trevisi 
and Bertoni 2008). The combination of these results indicates that it is possible that the reduction in 
systemic inflammation could be the mechanism by which the pregnancy rate was improved in the 
SCE cows. 
Two potential mechanisms by which systemic inflammation during the periparturient period could 
reduce reproductive performance have been proposed by Bertoni et al. (2008). Both of these 
mechanisms are associated with the effects of cytokines, whose production is stimulated by 
prostaglandins (Bos et al. 2004). The first potential mechanism is liver function impairment, which 
involves the diversion of liver protein synthesis from negative acute phase proteins (-APP) to positive 
acute phase proteins (+APP). When an inflammatory event occurs, pro-inflammatory cytokines 
promote the production of +APP proteins by the liver, such as globulin and haptoglobin, at the 
expense of the proteins normally produced by the liver, such as albumin and retinol binding protein 
(-APP), apolipoproteins, and the proteins involved in antioxidant activity or bilirubin clearance (Fleck 
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1989; Bertoni et al. 2008; Trevisi and Bertoni 2008). This reduction in liver function increases the risk 
of liver lipidosis and the risk of exposure to the negative effects of oxidative stress (Drackley et al. 
2005; Trevisi and Bertoni 2008), both of which have negative effects on the ovary and the embryo, 
and therefore reproduction (Rukkwamsuk et al. 1999; Guérin et al. 2001; Bobe et al. 2004). The 
second potential mechanism is the exacerbation of negative energy balance. Pro-inflammatory 
cytokines reduce feed intake (Johnson and Finck 2001) and increase energy expenditure (Elsasser et 
al. 2000). Combined, these two changes result in the exacerbation of negative energy balance, which 
has been reported to have detrimental effects on reproductive performance (Butler 2003; Friggens et 
al. 2010). These changes in energy balance and liver function could result in homeorhetic responses 
that divert biological resources from reproduction (Drackley et al. 2005), which would result in 
reduced reproductive performance in cows with systemic inflammation. 
In addition to the two mechanisms proposed by Bertoni et al. (2008), in the literature review 
(Chapter 2, section 2.8.2) it is reported that cytokines have negative effects on the reproductive axis 
which include inhibiting the release of hypothalamic GnRH (Rivest et al. 1993), reduction of 
oestradiol production by the granulosa cells of the ovary (Spicer and Alpizar 1994; Sheldon et al. 
2002; Sheldon et al. 2009), and the reduction of progesterone production by the luteal cells of the 
ovary (Petroff et al. 2001; Okuda and Sakumoto 2003; Sheldon et al. 2009). Therefore, the reduction 
in systemic inflammation, and thus systemic concentrations of cytokines, may have ameliorated 
these negative effects of cytokines on liver function, energy balance, and the reproductive axis, 
resulting in improved reproductive performance. 
5.1.3 Scenario 3 
While it is possible that either scenario 1 or 2, or a combination of the two scenarios, was the 
mechanism by which the NSAID treatment improved pregnancy rate in cows with SCE, it is also 
possible that the NSAID improved pregnancy rate through alternative pathways. One potential 
pathway is that the NSAID treatment altered the systemic prostaglandin profile (dashed black 
arrows), for example the ratio of PGF2α/PGE2 (luteolytic and luteotrophic, respectively, Arosh et al. 
(2004)), which may have had beneficial effects on the ovary and, therefore, reproductive 
performance. Alternatively, as cyclooxygenase not only catalyses the reaction for prostaglandin 
synthesis but also catalyses those for other eicosanoids such as thromboxane (Reilly and Fitzgerald 
1993), the NSAID treatment may have altered the systemic or uterine concentrations of these other 
eicosanoids (dashed purple arrows) in a way that was beneficial to reproductive performance. For 
example, thromboxane is a vasoconstrictor (Reilly and Fitzgerald 1993), thus, perhaps reducing the 
concentration of thromboxane could be beneficial to reproduction by allowing greater blood flow to 
the ovaries and/or the uterus, and therefore allowing a greater influx of beneficial factors to these 
organs. 
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5.2 Hypotheses generated 
Based on the scenarios discussed in the previous section, there are several hypotheses that can be 
generated. Testing these hypotheses could potentially result in the determination of the mechanism 
by which the pregnancy rate was improved in NSAID-treated SCE cows.  
To determine whether the pathway described in scenario 1 was the mechanism by which the NSAID 
treatment improved pregnancy rate in cows with SCE, the three key hypotheses to be tested are: 
 That a systemic NSAID treatment alters uterine prostaglandin profiles and reduces uterine 
inflammation (PMN %). 
 That a systemic NSAID results in a faster rate of decline of uterine inflammation (PMN %) in 
NSAID-treated cows compared with untreated cows. 
 Cows that have a faster reduction of uterine inflammation (PMN %) have higher pregnancy 
rates. 
The three key hypotheses for testing whether it was the pathways described in scenario 2 that was 
the mechanism by which the pregnancy rate was improved in cows with SCE are: 
 That treatment with a NSAID reduces systemic concentrations of pro-inflammatory 
cytokines. 
 That the reduction of systemic inflammation, specifically systemic concentrations of pro-
inflammatory cytokines, by a systemic NSAID treatment is associated with improved 
reproductive performance in treated cows compared with untreated cows. 
 That a systemic NSAID treatment, by reducing systemic inflammation and cytokine 
concentrations, improves liver function (increases –APP and decreases +APP concentrations) 
and energy balance (increases dry matter intake and reduces energy expenditure), and 
mitigates the negative effects of cytokines on follicle development, ovulation, and luteal 
function. 
For the pathways described in scenario 3, the three key hypotheses to test are: 
 That a systemic NSAID treatment alters the systemic prostaglandin profiles and reduces the 
systemic concentrations of the other eicosanoids (e.g. thromboxane). 
 That the alteration of systemic prostaglandin profiles by a NSAID treatment is beneficial to 
the pregnancy rate of treated cows. 
 That the reduction of systemic concentrations of thromboxane is beneficial to the pregnancy 
rate of treated cows. 
To test these hypotheses and determine the mechanism by which the NSAID treatment improved the 
pregnancy rate of cows with SCE would require a large program of work and several targeted studies. 
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Given the interrelated nature of these hypotheses, there is the potential for more than one 
hypothesis to be tested at the same time. The experimental model that is the most appropriate to 
test each hypothesis, e.g. SCE cows or cells in culture, will depend on where the priorities lie for the 
programme of work. For example, the programme may be focused on acquiring knowledge at the 
cellular level or at the whole cow level. However, whilst answering the question of how the NSAID 
treatment increased pregnancy rate in the SCE cows is important, it would take several studies across 
many years. This timeframe is not ideal for farmers who are dealing with the disease now. Therefore, 
it could be argued that it is not important to know how the NSAID treatment improved pregnancy 
rate, but simply to confirm that it does. In other words, can the result obtained in this experiment be 
replicated and validated? Further studies need to be conducted to validate whether the NSAID 
treatment does improve pregnancy rate in SCE cows and to optimise the treatment protocol (e.g. 
when to administer, how many injections). If the improvement in pregnancy rate obtained in the 
current experiment is validated, this would provide a usable result to farmers faster than any 
investigation of the mechanism by which the NSAID treatment improved pregnancy rate. However, 
as (1) blanket/mass treatment of all cows with a NSAID would be unacceptable, and (2) the NSAID 
treatment was not beneficial to any group of cows except for the SCE cows, the cows with or at risk 
of SCE would still need to be identified for treatment. This is where the use of a model to identify the 
cows at risk of SCE would come in. 
5.3 Identifying the cows with subclinical endometritis 
The hypothesis for the second experiment was that differences in serum metabolite concentrations 
and BCS between cows with and without SCE could provide information accurate enough to achieve 
the dual aim of predicting those cows at risk of SCE and reducing the number of cows undergoing 
cytology or proactive treatment to a manageable level. Although a model was developed that could 
identify 100% of the cows at risk of SCE, the model was unable to reduce the number requiring 
diagnosis or treatment to a manageable level. This result is in agreement with those reported by 
Kaufmann et al. (2010a), who was also unable to use serum metabolites to predict the cows with 
SCE. However, the importance of identifying cows at risk of SCE means that other biological markers 
or methods of detection need to be investigated. 
The markers used in the second experiment, e.g. ASAT, albumin, and NEFA, are indirect markers. In 
other words, the markers used are compounds that are not directly associated with uterine 
inflammation but are associated with a part of the physiological processes involved with SCE. Thus, 
these markers are only measures of physiological processes that occur at the systemic level, e.g. 
energy status, and they also undergo significant changes throughout the postpartum transition 
period. This means that finding an indirect/systemic marker(s) that is able to predict the cows at risk 
of SCE will be challenging. Therefore, markers that are directly affected by, or are part of the process 
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of uterine inflammation need to be found, as these may be the best candidates to use for the 
prediction of at-risk cows or the rapid diagnosis of cows with SCE. To identify direct markers for SCE, 
further research into the aetiology of SCE is needed, so that cause and effect for SCE can be 
determined and potential markers identified. 
Possibilities for research into the aetiology of SCE include investigating the causes of SCE uterine 
inflammation, e.g. the role of the pre-calving physiological dysfunction reported by Burke et al. 
(2010) and Priest et al. (2013), and investigating the role of the neutrophil and potential immune 
system dysfunction reported by Hammon et al. (2006), Galvão et al. (2010), and Hansen (2013). 
However, in order to conduct an experiment that is more than just an association study, an 
experiment would need to be conducted on a small population (a large population would be 
logistically impractical) that was intensively measured. The study population would need to be 
comprised of cows that had been selected to generate an experimental cow model. For example, to 
investigate causes of the inflammation associated with SCE, and knowing that cows with SCE have 
both systemic and uterine inflammation, the experimental population should include the following 
four groups of cows: cows with only systemic inflammation, cows with only uterine inflammation, 
cows with both systemic and uterine inflammation, and cows that do not have any inflammation at 
all. After collecting detailed measurements from these cows, markers for each group of cows could 
potentially be identified. If markers were identified for each group, to try to figure out the causes of 
SCE inflammation, a group of cows that do not have any systemic or uterine inflammation would 
need to be manipulated in some way, e.g. alter BCS, to see if the manipulation induces expression of 
the identified markers. If the manipulation does induce expression of the identified markers, then 
the effect of the manipulation is a part of the cause of SCE. Markers specific to this effect, and 
therefore to SCE, could then be investigated to provide candidates for either predicting or detecting 
SCE. 
Although further research may identify direct markers, their value must be assessed in relation to the 
cost and practicality of collecting these data. In other words, although a direct marker may be 
identified that can be used to predict cows at risk of SCE, or to diagnose cows with SCE, the 
practicality and cost of collecting and measuring the direct marker must be taken into account when 
determining whether the marker is appropriate for on-farm SCE management. However, if a direct 
marker is identified that is initially impractical or too costly to collect or measure, advances in 
technology may result in the subsequent development of more practical and cost effective ways to 
either collect or measure the marker. Additionally, advances in technology, such as mass 
spectrometry, may allow more in-depth and faster analyses of blood, milk, and uterine mucus, which 
may result in the identification of direct markers in these easy-to-collect body fluids. 
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Alternatively, perhaps we should focus on the herd rather than on individual cows for management 
of SCE. This approach would mean that instead of trying to determine if individual cows have the 
disease in the first instance, we would start by investigating whether the herd is at risk of SCE. A herd 
at risk of SCE could be defined as having a high proportion of cows that had experienced assisted 
calving, twinning, dystocia, etc. (the risk factors for SCE listed in section 2.4, Table 2). If the herd is at-
risk, then submit the whole herd for cytology. If the herd is assessed to be not-at-risk, then do not 
test the herd at all. This herd-risk assessment approach would reduce the costs of determining 
whether a cow should be submitted for cytology or not, but introduces the possibility of overlooking 
a potential SCE problem in herds that have been assessed to be at low risk. This is because over half 
of the cows with endometritis do not have any of the risk factors listed in section 2.4, Table 2 
(LeBlanc et al. 2002a). This would potentially result in herds being assessed as having a low risk of 
SCE when the actual prevalence of SCE in the herd is much higher. Based on a SCE prevalence ranging 
from 5 to 50% (Table 8), not identifying and treating cows with SCE could potentially be reducing the 
herd’s 6-week in-calf rate by 1 to 14%, increasing the herd’s empty rate by 2 to 15%, and reducing 
potential farm profit by $20 to 204/cow/year. This negative impact on reproduction and farm profit if 
SCE cows are not identified and treated means that until more accurate herd risk factors are 
identified, individual cow assessment for either risk of SCE, or diagnosis of SCE, is the best option for 
reducing the negative effect of SCE on reproduction and farm profit. However, although there are 
obvious negative impacts if the cows with SCE within a herd are not treated, it is acknowledged that 
the cost of identifying and treating the cows with SCE must be taken into account when calculating 
the cost/benefit for SCE management. 
Table 8: The impact1 of varying levels of subclinical endometritis on the reproductive performance 
and farm profitability of a 400 cow herd with a 12 week mating period 
Herd subclinical endometritis prevalence 
 0% 5% 10% 20% 30% 40% 50% 
6-week in-calf rate 70% 68.75% 67.5% 65.0% 62.5% 60.0% 57.5% 
Empty rate2 10% 11.5% 13% 16% 19% 22% 25% 
Economic loss/year $0 $8000 $16000 $32000 $48000 $64000 $80000 
Economic loss/cow/year $0 $20 $40 $81 $122 $163 $204 
1For the assumptions used and calculations made to obtain these values, see Appendix A. 
2Empty rate is the percentage of cows in the herd that are diagnosed as not pregnant at the final 
pregnancy testing after 12 weeks of mating. 
5.4 Conclusions and implications 
If either scenario 1 or 2 was the mechanism by which pregnancy rate was improved, or if both 
contributed to increasing the pregnancy rate of SCE cows, this would suggest that the inflammation 
 60 
associated with SCE is a part of the mechanism by which the reproductive performance of SCE cows 
is reduced. This conclusion is in contrast to those studies which report (or base their hypotheses on 
the assumption) that reproductive performance of cows with endometritis/SCE is reduced by 
bacteria (Williams et al. 2005; Galvão et al. 2009b; Herath et al. 2009; Sheldon et al. 2009; LeBlanc et 
al. 2011), but is congruent with studies reporting a stronger association of poor reproductive 
performance with uterine inflammation (as assessed by PMN %) than with the presence of bacteria 
in the uterus postpartum (McDougall et al. 2011; Barański et al. 2012). One implication of this 
conclusion is that treatment of SCE should be focusing on reducing the inflammation associated with 
SCE, both pre- and postpartum, instead of simply trying to eliminate bacteria from the uterus. 
Another implication is that research into markers for SCE prediction or diagnosis should focus on 
markers that are associated with inflammation, both the causes of and the products of inflammation. 
However, as identified in the literature review, the question still remains, where does this 
inflammation, both systemic and uterine, come from? If the source of the inflammation could be 
identified, then it may be possible to develop management strategies to prevent or at least reduce 
the prevalence of SCE, and thus reduce the need to treat cows for this disease in the first place, or 
provide better candidate markers for SCE prediction or detection. Therefore, future studies need to 
investigate what the causes of the systemic inflammation and uterine inflammation are, and whether 
the systemic inflammation is a result of whatever is causing SCE or a part of the cause of SCE itself, or 
whether the systemic inflammation is a part of a presently unidentified disease that is occurring 
concurrently with SCE. It must be noted though, that the costs of making herd management changes, 
identifying the cows at risk of SCE or diagnosing those with SCE, and treating the affected cows, must 
be taken into account when considering whether a particular approach to reducing the prevalence of 
or identifying/treating cows with SCE will beneficial or not. 
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Appendix A 
Calculating the cost of subclinical endometritis  
The values reported in Table 8 of the General Discussion (Chapter 5) were calculated using the ‘gap 
calculator’ from the InCalf Economics of Reproductive Performance Tool (InCalf 2013) and data from 
McDougall et al. (2011). The assumptions for these calculations were that the herd comprised of 400 
cows and had a 12 week mating period. 
The first step for calculating the values in Table 8 was to identify the difference in 6-week in-calf rate 
and empty rate between cows with and without SCE. The 6-week in-calf rate was defined as the 
percentage of cows pregnant by six weeks after the start of the mating period. The empty rate was 
the percentage of cows that were not diagnosed as pregnant at the final pregnancy diagnosis after 
the herd had been submitted for 12 weeks of mating. I estimated the 6-week in-calf and empty rates 
for the cows with and without SCE from the percentages displayed in the figure reported by 
McDougall et al. (2011) (Figure A.1). The blue lines in Figure A.1 indicate the approximate 6-week in-
calf rates for cows with (45%) and without SCE (70%). The purple lines indicate the approximate 
empty rates for the cows with (40%) and without SCE (10%). 
 
Figure A.1: Cumulative proportion of cows pregnant for cows with (◊) and without (●) subclinical 
endometritis. McDougall et al. (2011), reproduced with permission from Elsevier. 
Using the estimated 6-week in-calf rate and empty rate percentages, I calculated what the herds 6-
week in-calf rate and empty rate would be, based on a prevalence of SCE ranging from 5 to 50% 
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(Table A.1). This range of prevalences was used as they span the range reported in the literature 
(Gilbert et al. 2005; Green et al. 2009). 
Table A.1: The impact of varying levels of subclinical endometritis on herd reproductive 
performance 
Herd subclinical endometritis prevalence 
 0% 5% 10% 20% 30% 40% 50% 
6-week in-calf rate 70% 68.75% 67.5% 65.0% 62.5% 60.0% 57.5% 
Empty rate 10% 11.5% 13% 16% 19% 22% 25% 
The second step was to calculate the potential economic loss due to the reduced reproductive 
performance of the SCE cows within the herd across the various prevalences. Firstly I calculated the 
dollar value of the difference between the obtained 6-week in-calf rate (e.g. 68.75% for a herd with a 
SCE prevalence of 5%) and desired 6-week in-calf rate (i.e. the 6-week in-calf rate for a herd without 
SCE, 70%). The equation for this calculation is Equation 1 (below), where A is the economic loss, B is 
the observed 6-week in-calf rate and C is the desired 6-week in-calf rate. The dollar value ($4) in the 
equation is an economic multiplier (supplied in the tool) that was estimated through modelling 
assuming a $5.50 per kg milksolids pay-out. 
 
Equation 1: Equation used to calculate the dollar value for the difference between the obtained 6-
week in-calf rate and the desired 6-week in-calf rate. The letters used in this equation are 
explained in the text above. 
Next, I calculated the dollar value for the difference between the obtained empty rate (e.g. 11.5% for 
a herd with a SCE prevalence of 5%) and desired empty rate (i.e. the empty rate for a herd without 
SCE, 10%). The equation for this calculation is Equation 2 (below), where D is the economic loss, E is 
the obtained empty rate and F is the desired empty rate. The dollar value ($10) in the equation is an 
economic multiplier (supplied in the tool) that assumes a $1000 value differential between an empty 
and in-calf cow. 
 
Equation 2: Equation used to calculate the dollar value for the difference between the obtained 
empty rate and the desired empty rate. The letters used in this equation are explained in 
the text above. 
The dollar value for the overall reduction in herd reproductive performance was calculated by adding 
A from Equation 1 (the dollar value for the difference between the obtained 6-week in-calf rate and 
the desired 6-week in-calf rate) to D from Equation 2 (the dollar value for the difference between the 
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obtained empty rate and the desired empty rate). The values calculated for A, D, and their combined 
total, are displayed in Table A.2. 
Table A.2: Economic loss for the differences between obtained and desired 6-week in-calf rates 
and empty rates for a herd with varying prevalence of subclinical endometritis. 
         Herd subclinical endometritis prevalence 
 5% 10% 20% 30% 40% 50% 
6-week in-calf rate loss (A) $2,000 $4,000 $8,000 $12,000 $16,000 $20,000 
Empty rate loss (D) $6,000 $12,000 $24,000 $36,000 $48,000 $60,000 
Total $ loss per year (A + D) $8,000 $16,000 $32,000 $48,000 $64,000 $80,000 
Economic loss/cow/year $20 $40 $81 $122 $163 $204 
 
 
 64 
References 
Alberts B, Johnson A, Walter P, Lewis G, Raff M, Roberts K. 2007. Molecular biology of the cell. 5th 
ed. Pages 1450-1462. Taylor &Francis Inc, New York, United States of America. 
Anderson KL. 1990: Pharmacokinetics of flunixin meglumine in lactating cattle after single and 
multiple intramuscular and intravenous administrations. American Journal of Veterinary Research 
51:1464-1467. 
Anderson KL, Hemeida NA, Frank A, Whitmore HL, Gustafsson BK. 1985: Collection and phagocytic 
evaluation of uterine neutrophilic leukocytes. Theriogenology 24:305-317. 
Arosh JA, Banu SK, Kimmins S, Chapdelaine P, MacLaren LA, Fortier MA. 2004: Effect of interferon-τ 
on prostaglandin biosynthesis, transport, and signalling at the time of maternal recognition of 
pregnancy in cattle: evidence of polycrine actions of prostaglandin E2. Endocrinology 145:5280-5293. 
Back PJ, Lopdell T, Berg MC, Green MP. 2011: Sub-clinical uterine infection is associated with altered 
amino acid concentrations of follicular fluid in early lactation dairy cows. Proceedings of the New 
Zealand Society of Animal Production 71:296-300. 
Barański W, Podhalicz-Dzięgielewska M, Zduńczyk S, Janowski T. 2012: The diagnosis and prevalence 
of subclinical endometritis in cows evaluated by different cytologic thresholds. Theriogenology 
78:1939-1947. 
Barlund CS, Carruthers TD, Waldner CL, Palmer CW. 2008: A comparison of diagnostic techniques for 
postpartum endometritis in dairy cattle. Theriogenology 69:714-723. 
Battaglia DF, Beaver AB, Harris TG, Tanhehco E, Viguie C, Karsch FJ. 1999: Endotoxin disrupts the 
estradiol-induced luteinizing hormone surge: Interference with estradiol signal reading, not surge 
release. Endocrinology 140:2471-2479. 
Bazer FW, Spencer TE, Ott TL. 1997: Interferon tau: a novel pregnancy recognition signal. American 
Journal of Reproductive Immunology 37:412-420. 
Bell MJ and Roberts DJ. 2007: The impact of uterine infection on a dairy cow's performance. 
Theriogenology 68:1074-1079. 
Bertoni G, Trevisi E, Han X, Bionaz M. 2008: Effects of inflammatory conditions on liver activity in 
puerperium period and consequences for performance in dairy cows. Journal of Dairy Science 
91:3300-3310. 
 65 
Blackwell MB, Burke CR, Verkerk GA. 2010. Reproductive management practices in New Zealand 
dairy farms: What will the future hold in a consumer-focused, export-driven marketplace? Pages 406-
416 in Proc. 4th Australasian Dairy Science Symposium, Lincoln, New Zealand. 
Bobe G, Young JW, Beitz DC. 2004: Invited Review: Pathology, etiology, prevention, and treatment of 
fatty liver in dairy cows. Journal of Dairy Science 87:3105-3124. 
Bondurant RH. 1999: Inflammation in the bovine female reproductive tract. Journal of Animal Science 
77 (Supplement 2):101-110. 
Bos CL, Richel DJ, Ritsema T, Peppelenbosch MP, Versteeg HH. 2004: Prostanoids and prostanoid 
receptors in signal transduction. The International Journal of Biochemistry & Cell Biology 36:1187-
1205. 
Bretzlaff K. 1987: Rationale for treatment of endometritis in the dairy cow. Veterinary Clinics of North 
America: Food Animal Practice 3:593-607. 
Burke C, Blackwell M, Little S, Macmillan J, Xu Z, McDougall S. 2007. The InCalf book for New Zealand 
dairy farmers. Pages 27-166. DairyNZ, Hamilton, New Zealand. 
Burke CR, Meier S, McDougall S, Compton C, Mitchell M, Roche JR. 2010: Relationships between 
endometritis and metabolic state during the transition period in pasture-grazed dairy cows. Journal 
of Dairy Science 93:5363-5373. 
Burke CR and Verkerk GA. 2010: The development of reproductive management practices in New 
Zealand: what will the future hold in a consumer-focused, environmentally-conscious, export-driven 
marketplace? Reproduction in Domestic Ruminants 7:339-353. 
Butler WR. 2003: Energy balance relationships with follicular development, ovulation and fertility in 
postpartum dairy cows. Livestock Production Science 83:211-218. 
Cheong SH, Nydam DV, Galvão KN, Crosier BM, Gilbert RO. 2011a: Cow-level and herd-level risk 
factors for subclinical endometritis in lactating Holstein cows. Journal of Dairy Science 94:762-770. 
Cheong SH, Nydam DV, Galvão KN, Crosier BM, Ricci A, Caixeta LS, Sper RB, Fraga M, Gilbert RO. 
2011b: Use of reagent test strips for diagnosis of endometritis in dairy cows. Theriogenology 77:858-
864. 
Couto GB, Vaillancourt DH, Lefebvre RC. 2012: Comparison of a leukocyte esterase test with 
endometrial cytology for diagnosis of subclinical endometritis in postpartum dairy cows. 
Theriogenology 79:103-107. 
 66 
Drackley JK, Dann HM, Douglas GN, Janovick Guretzky NA, Litherland NB, Underwood JP, Loor JJ. 
2005: Physiological and pathological adaptations in dairy cows that may increase susceptibility to 
periparturient diseases and disorders. Italian Journal of Animal Science 4:323-344. 
Drillich M, Raab D, Wittke M, Heuwieser W. 2005: Treatment of chronic endometritis in dairy cows 
with an intrauterine application of enzymes: A field trial. Theriogenology 63:1811-1823. 
Drillich M, Voigt D, Forderung D, Heuwieser W. 2007: Treatment of acute puerperal metritis with 
flunixin meglumine in addition to antibiotic treatment. Journal of Dairy Science 90:3758-3763. 
Dubuc J, Duffield TF, Leslie KE, Walton JS, LeBlanc SJ. 2010: Definitions and diagnosis of postpartum 
endometritis in dairy cows. Journal of Dairy Science 93:5225-5233. 
Dubuc J, Duffield TF, Leslie KE, Walton JS, Leblanc SJ. 2011: Effects of postpartum uterine diseases on 
milk production and culling in dairy cows. Journal of Dairy Science 94:1339-1346. 
Duffield TF, Lissemore KD, McBride BW, Leslie KE. 2009: Impact of hyperketonemia in early lactation 
dairy cows on health and production. Journal of Dairy Science 92:571-580. 
Elliott WH and Elliott DC. 1997. Biochemistry and molecular biology. Vol. 1. Pages 146-147. Oxford 
University Press, Oxford, United Kingdom. 
Elsasser TH, Klasing KC, Filipov N, Thompson F. 2000. The metabolic consequences of stress: Targets 
for stress and priorities of nutrient use. Pages 77-110. 2 ed. G. P. Moberg and J. A. Mench, ed. CABI 
Publishing, New York, United States of America. 
Erdem H and Guzeloglu A. 2010: Effect of meloxicam treatment during early pegnancy in holstein 
heifers. Reproduction in Domestic Animals 45:625-628. 
Fischer C, Drillich M, Odau S, Heuwieser W, Einspanier R, Gabler C. 2010: Selected pro-inflammatory 
factor transcripts in bovine endometrial epithelial cells are regulated during the oestrous cycle and 
elevated in case of subclinical or clinical endometritis. Reproduction, Fertility and Development 
22:818-829. 
Fleck A. 1989: Clinical and nutritional aspects of changes in acute-phase proteins during 
inflammation. Proceedings of the Nutrition Society 48:347-354. 
Fortune JE. 1994: Ovarian follicular growth and development in mammals. Biology of Reproduction 
50:225-232. 
 67 
Fourichon C, Seegers H, Bareille N, Beaudeau F. 1999: Effects of disease on milk production in the 
dairy cow: a review. Preventive Veterinary Medicine 41:1-35. 
Friggens NC, Disenhaus C, Petit HV. 2010: Nutritional sub-fertility in the dairy cow: towards improved 
reproductive management through a better biological understanding. Animal 4:1197-1213. 
Gabler C, Drillich M, Fischer C, Holder C, Heuwieser W, Einspanier R. 2009: Endometrial expression of 
selected transcripts involved in prostaglandin synthesis in cows with endometritis. Theriogenology 
71:993-1004. 
Gabler C, Fischer C, Drillich M, Einspanier R, Heuwieser W. 2010: Time-dependent mRNA expression 
of selected pro-inflammatory factors in the endometrium of primiparous cows postpartum. 
Reproductive Biology and Endocrinology 8:1-9. 
Galvão KN, Flaminio MJBF, Brittin SB, Sper R, Fraga M, Caixeta L, Ricci A, Guard CL, Butler WR, Gilbert 
RO. 2010: Association between uterine disease and indicators of neutrophil and systemic energy 
status in lactating Holstein cows. Journal of Dairy Science 93:2926-2937. 
Galvão KN, Frajblat M, Brittin SB, Butler WR, Guard CL, Gilbert RO. 2009a: Effect of prostaglandin F2a 
on subclinical endometritis and fertility in dairy cows. Journal of Dairy Science 92:4906-4913. 
Galvão KN, Greco LF, Vilela JM, Sa Filho MF, Santos JE. 2009b: Effect of intrauterine infusion of 
ceftiofur on uterine health and fertility in dairy cows. Journal of Dairy Science 92:1532-1542. 
Galvão KN, Santos NR, Galvão JS, Gilbert RO. 2011: Association between endometritis and 
endometrial cytokine expression in postpartum Holstein cows. Theriogenology 76:290-299. 
Gautam G, Nakao T, Yusuf M, Koike K. 2009: Prevalence of endometritis during the postpartum 
period and its impact on subsequent reproductive performance in two Japanese dairy herds. Animal 
Reproduction Science 116:175-187. 
Ghasemi F, Gonzalez-Cano P, Griebel PJ, Palmer C. 2012: Proinflammatory cytokine gene expression 
in endometrial cytobrush samples harvested from cows with and without subclinical endometritis. 
Theriogenology 78:1538-1547. 
Gilbert RO, Shin ST, Guard CL, Erb HN, Frajblat M. 2005: Prevalence of endometritis and its effects on 
reproductive performance of dairy cows. Theriogenology 64:1879-1888. 
Goff JP. 2008: The monitoring, prevention, and treatment of milk fever and subclinical hypocalcemia 
in dairy cows. The Veterinary Journal 176:50-57. 
 68 
Green MP, Ledgard AM, Beaumont SE, Berg MC, McNatty KP, Peterson AJ, Back PJ. 2011: Long-term 
alteration of follicular steroid concentrations in relation to subclinical endometritis in postpartum 
dairy cows. Journal of Animal Science 89:3551-3560. 
Green MP, Ledgard AM, Berg MC, Peterson AJ, Back PJ. 2009: Prevalence and identification of 
systemic markers of sub-clinical endometritis in postpartum dairy cows. Proceedings of the New 
Zealand Society of Animal Production 69:37-42. 
Grimble RF. 2001: Stress proteins in disease: metabolism on a knife edge. Clinical nutrition 
(Edinburgh, Scotland) 20:469-476. 
Guérin P, El Mouatassim S, Ménézo Y. 2001: Oxidative stress and protection against reactive oxygen 
species in the pre-implantation embryo and its surroundings. Human Reproduction Update 7:175-
189. 
Guzeloglu A, Erdem H, Saribay M, Thatcher W, Tekeli T. 2007: Effect of the administration of flunixin 
meglumine on pregnancy rates in Holstein heifers. The Veterinary Record 160:404-406. 
Hammon DS, Evjen IM, Dhiman TR, Goff JP, Walters JL. 2006: Neutrophil function and energy status 
in Holstein cows with uterine health disorders. Veterinary Immunology and Immunopathology 
113:21-29. 
Hansen PJ. 2013: PHYSIOLOGY AND ENDOCRINOLOGY SYMPOSIUM: Maternal immunological 
adjustments to pregnancy and parturition in ruminants and possible implications for postpartum 
uterine health: Is there a prepartum-postpartum nexus? Journal of Animal Science 91:1639-1649. 
Harris BL, Pryce JE, Xu ZZ, Montgomerie WA. 2006: Development of new fertility breeding values in 
the dairy industry. Proceedings of the New Zealand Society of Animal Production 66:107-112. 
Heidarpour M, Mohri M, Fallah Rad AH, Shahreza FD, Mohammadi M. 2012: Acute-phase protein 
concentration and metabolic status affect the outcome of treatment in cows with clinical and 
subclinical endometritis. Veterinary Record 171:1-5. 
Herath S, Lilly ST, Fischer DP, Williams EJ, Dobson H, Bryant CE, Sheldon IM. 2009: Bacterial 
Lipopolysaccharide Induces an Endocrine Switch from Prostaglandin F2α to Prostaglandin E2 in 
Bovine Endometrium. Endocrinology 150:1912-1920. 
Herath S, Williams EJ, Lilly ST, Gilbert RO, Dobson H, Bryant CE, Sheldon IM. 2007: Ovarian follicular 
cells have innate immune capabilities that modulate their endocrine function. Reproduction 134:683-
693. 
 69 
Heuwieser W, Iwersen M, Goetze L. 2011: Efficacy of carprofen on conception rates in lactating dairy 
cows after subcutaneous or intrauterine administration at the time of breeding. Journal of Dairy 
Science 94:146-151. 
Hill J and Gilbert R. 2008: Reduced quality of bovine embryos cultured in media conditioned by 
exposure to an inflamed endometrium. Australian Veterinary Journal 86:312-316. 
Holmes CW, Brookes IM, Garrick DJ, Mackenzie DDS, Parkinson TJ, Wilson GF. 2002. Milk production 
from pasture. Principles and practices. Pages 5-36. Massey University, Palmerston North, New 
Zealand. 
Hussain AM. 1989: Bovine uterine defense mechanisms: A review. Journal of Veterinary Medicine, 
Series B 36:641-651. 
Huzzey JM, Duffield TF, LeBlanc SJ, Veira DM, Weary DM, von Keyserlingk MA. 2009: Short 
communication: Haptoglobin as an early indicator of metritis. Journal of Dairy Science 92:621-625. 
Huzzey JM, Veira DM, Weary DM, von Keyserlingk MA. 2007: Prepartum behavior and dry matter 
intake identify dairy cows at risk for metritis. Journal of Dairy Science 90:3220-3233. 
InCalf. 2013: Economics of reproductive performance tool. in InCalf Herd assessment tools. DairyNZ. 
http://www.dairynz.co.nz/page/pageid/2145861791/InCalf_Herd_Assessment_Tools 
Janeway CA, Travers P, Walport M, Shlomchik M. 2001. Immunobiology: The immune system in 
health and disease. 5 ed. Pages 382-388. Garland Publishing 2001, New York. 
Johnson RW and Finck BN. 2001: Tumor necrosis factor alpha and leptin: Two players in an animal's 
metabolic and immunologic responses to infection. Journal of Animal Science 79:E118-E127. 
Kasimanickam R, Duffield TF, Foster RA, Gartley CJ, Leslie KE, Walton JS, Johnson WH. 2004: 
Endometrial cytology and ultrasonography for the detection of subclinical endometritis in 
postpartum dairy cows. Theriogenology 62:9-23. 
Kasimanickam R, Duffield TF, Foster RA, Gartley CJ, Leslie KE, Walton JS, Johnson WH. 2005a: A 
comparison of the cytobrush and uterine lavage techniques to evaluate endometrial cytology in 
clinically normal postpartum dairy cows. The Canadian Veterinary Journal. La Revue Veterinaire 
Canadienne 46:255-259. 
Kasimanickam R, Duffield TF, Foster RA, Gartley CJ, Leslie KE, Walton JS, Johnson WH. 2005b: The 
effect of a single administration of cephapirin or cloprostenol on the reproductive performance of 
dairy cows with subclinical endometritis. Theriogenology 63:818-830. 
 70 
Kaufmann T, Drillich M, Tenhagen B-A, Heuwieser W. 2010a: Correlations between periparturient 
serum concentrations of non-esterified fatty acids, beta-hydroxybutyric acid, bilirubin, and urea and 
the occurrence of clinical and subclinical postpartum bovine endometritis. BMC Veterinary Research 
6:47. 
Kaufmann TB, Westermann S, Drillich M, Plontzke J, Heuwieser W. 2010b: Systemic antibiotic 
treatment of clinical endometritis in dairy cows with ceftiofur or two doses of cloprostenol in a 14-d 
interval. Animal Reproduction Science 121:55-62. 
Keogh J. 2011. Schaum's Outline of Medical Terminology. Illustrated ed. McGraw-Hill publishing, New 
York, United States of America. 
Kimura K, Reinhardt TA, Goff JP. 2006: Parturition and hypocalcemia blunts calcium signals in 
immune cells of dairy cattle. Journal of Dairy Science 89:2588-2595. 
Kluciński W, Targowski SP, Miernik-Degórska E, Winnicka A. 1990: The phagocytic activity of 
polymorphonuclear leucocytes isolated from normal uterus and that with experimentally induced 
inflammation in cows. Journal of Veterinary Medicine Series A 37:506-512. 
Knutti B, Kupfer U, Busato A. 2000: Reproductive efficiency of cows with endometritis after 
treatment with intrauterine infusions or prostaglandin injections, or no treatment. Journal of 
Veterinary Medicine Series A 47:609-615. 
LeBlanc SJ. 2008: Postpartum uterine disease and dairy herd reproductive performance: A review. 
The Veterinary Journal 176:102-114. 
LeBlanc SJ, Duffield TF, Leslie KE, Bateman KG, Keefe GP, Walton JS, Johnson WH. 2002a: Defining 
and diagnosing postpartum clinical endometritis and its impact on reproductive performance in dairy 
cows. Journal of Dairy Science 85:2223-2236. 
LeBlanc SJ, Duffield TF, Leslie KE, Bateman KG, Keefe GP, Walton JS, Johnson WH. 2002b: The effect 
of treatment of clinical endometritis on reproductive performance in dairy cows. Journal of Dairy 
Science 85:2237-2249. 
LeBlanc SJ, Osawa T, Dubuc J. 2011: Reproductive tract defense and disease in postpartum dairy 
cows. Theriogenology 76:1610-1618. 
Lewis G. 2003: Steroidal regulation of uterine resistance to bacterial infection in livestock. 
Reproductive Biology and Endocrinology 1:117. 
Lewis GS. 1997: Uterine health and disorders. Journal of Dairy Science 80:984-994. 
 71 
Li P, Yin Y-L, Li D, Woo Kim S, Wu G. 2007: Amino acids and immune function. British Journal of 
Nutrition 98:237-252. 
Lopdell T, Berg MC, Green MP, Back PJ. 2011: Effect of sub-clinical uterine infection on plasma amino 
acid concentrations in early lactation dairy cows. Proceedings of the New Zealand Society of Animal 
Production 71:291-295. 
Low BG and Hansen PJ. 1988: Actions of steroids and prostaglandins secreted by the placenta and 
uterus of the cow and ewe on lymphocyte proliferation in vitro. American Journal of Reproductive 
Immunology and Microbiology 18:71-75. 
Ludwig B, Jordan JC, Rehm WF, Thun R. 1989: Carprofen in veterinary medicine. I. Plasma disposition, 
milk excretion and tolerance in milk-producing cows. Schweizer Archiv Für Tierheilkunde 131:99-106. 
Macmillan KL. 1998. Reproductive management of dairy cattle. Pages 91-112. Occ. Pub. No 12 ed. E. 
D. Fielden and J. F. Smith, ed. New Zealand Society of Animal Production, Hamilton, New Zealand. 
Madoz LV, Giuliodori MJ, Plontzke J, Drillich M, de la Sota RL. 2013: The relationship between 
endometrial cytology during estrus cycle and cutoff points for the diagnosis of subclinical 
endometritis in grazing dairy cows. Journal of Dairy Science 96 (In press). 
Mateus L and da Costa LL. 2002: Peripartum blood concentrations of calcium, phosphorus and 
magnesium in dairy cows with normal puerperium or puerperal endometritis. Revista Portuguesa de 
Ciencias Veterinarias 97:35-38. 
McClatchey KD. 2002. Clinical laboratory medicine. 2nd ed. Pages 272. Lippincott Williams & Wilkins, 
Philadelphia, United States of America. 
McDougall S. 2001: Effects of periparturient diseases and conditions on the reproductive 
performance of New Zealand dairy cows. New Zealand Veterinary Journal 49:60-67. 
McDougall S, Hussein H, Aberdein D, Buckle K, Morgan S, Roche JR, Burke CR, Mitchell MD, Meier S, 
Compton C. 2009. Diagnosis and consequence of endometritis. Pages 231-241 in Proceedings of the 
Society of Dairy Cattle Veterinarians of the New Zealand Veterinary Association. Vol. 26. T. J. 
Parkinson, ed. VetLearn, Energy Events Centre, Rotorua, New Zealand. 
McDougall S, Hussein H, Aberdein D, Buckle K, Roche J, Burke C, Mitchell M, Meier S. 2011: 
Relationships between cytology, bacteriology and vaginal discharge scores and reproductive 
performance in dairy cattle. Theriogenology 76:229-240. 
 72 
McDougall S, Macaulay R, Compton C. 2007: Association between endometritis diagnosis using a 
novel intravaginal device and reproductive performance in dairy cattle. Animal Reproduction Science 
99:9-23. 
McLeod BJ and Phillips DJ. 1998. Hormonal control of reproduction. Pages 3-41. Occ. Pub. No 12 ed. 
E. D. Fielden and J. F. Smith, ed. New Zealand Society of Animal Production, Hamilton. 
Meira Jr EBS, Henriques LCS, Sá LRM, Gregory L. 2012: Comparison of ultrasonography and 
histopathology for the diagnosis of endometritis in Holstein-Friesian cows. Journal of Dairy Science 
95:6969-6973. 
Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. 1993: Selectivity of nonsteroidal 
antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proceedings of the 
National Academy of Sciences 90:11693-11697. 
Moenter SM, Caraty A, Karsch FJ. 1990: The estradiol-induced surge of gonadotropin-releasing 
hormone in the ewe. Endocrinology 127:1375-1384. 
Moyes KM, Larsen T, Ingvartsen KL. 2013: Generation of an index for physiological imbalance and its 
use as a predictor of primary disease in dairy cows during early lactation. Journal of Dairy Science 
96:2161-2170. 
Nakao T, Moriyoshi M, Kawata K. 1988: Effect of postpartum intrauterine treatment with 2 % 
polyvinyl-pyrrolidone-iodine solution on reproductive efficiency in cows. Theriogenology 30:1033-
1043. 
Norbrook. 2011: Carprieve 50mg/ml solution for injection for cattle. in Cattle products. Norbrook 
Laboratories. http://www.norbrook.com/products/carprieve-50mg-ml-solution-for-injection-for-
cattle 
Okuda K and Sakumoto R. 2003: Multiple roles of TNF super family members in corpus luteum 
function. Reproductive Biology and Endocrinology 1:1-10. 
Opsomer G, GrÃhn YT, Hertl J, Coryn M, Deluyker H, de Kruif A. 2000: Risk factors for post partum 
ovarian dysfunction in high producing dairy cows in Belgium: A field study. Theriogenology 53:841-
857. 
Paape M, Mehrzad J, Zhao X, Detilleux J, Burvenich C. 2002: Defense of the bovine mammary gland 
by polymorphonuclear neutrophil leukocytes. Journal of Mammary Gland Biology and Neoplasia 
7:109-121. 
 73 
Parkinson TJ, Vermunt JJ, Malmo J. 2007. Uterine infections: causes, management and sequelae. 
Pages 139-153 in Proc. Proceedings of the Society of Dairy Cattle Veterinarians of the New Zealand 
Veterinary Association, Palmerston North. 
Parkinson TJ, Vermunt JJ, Malmo J. 2010. Diseases of cattle in Australasia: A comprehensive 
textbook. 1st ed. Pages 60-526. The New Zealand Veterinary Association Foundation for Continuing 
Education, Wellington, New Zealand. 
Parsons AJ. 1988. The effects of season and management on the growth of grass swards. Pages 129-
177. M. B. Jones and A. Lazenby, ed. Chapman and Hall, London, United Kingdom. 
Petroff M, Petroff B, Pate J. 2001: Mechanisms of cytokine-induced death of cultured bovine luteal 
cells. Reproduction 121:753-760. 
Pleticha S and Heuwieser W. 2009: Definition and diagnosis of chronic endometritis in cattle: a 
review. Deutsche Tierarztliche Wochenschrift 116:164-172. 
Plöntzke J, Madoz LV, De la Sota RL, Drillich M, Heuwieser W. 2010: Subclinical endometritis and its 
impact on reproductive performance in grazing dairy cattle in Argentina. Animal Reproduction 
Science 122:52-57. 
Priest NV, McLeod K, McDougall S, Burke CR, Roche JR, Mitchell M, Meier S. 2012a: Associations of 
uterine pathology with milk production and effects of treatment with a non-steroidal anti-
inflammatory drug in dairy cows. Proceedings of the New Zealand Society of Animal Production 
72:23-27. 
Priest NV, McLeod K, McDougall S, Burke CR, Roche JR, Mitchell M, Meier S. 2012b. Treatment of 
subclinical endometritis in dairy cows with a non-steroidal anti-inflammatory drug. Pages 290-293 in 
Proc. 5th Australasian Dairy Science Symposium, Melbourne, Australia. 
Priest NV, McLeod KL, McDougall S, Burke CR, Roche JR, Mitchell MD, Greenwood SL, Meier S. 2013: 
The responsiveness of subclinical endometritis to a non-steroidal anti-inflammatory drug in pasture-
grazed dairy cows. Journal of Dairy Science 96 (In press), DOI 10.3168/jds.2012-6266 
Reilly M and Fitzgerald GA. 1993: Cellular activation by thromboxane A2 and other eicosanoids. 
European Heart Journal 14 (Supplement K):88-93. 
Rhodes FM, McDougall S, Burke CR, Verkerk GA, Macmillan KL. 2003: Invited Review: Treatment of 
cows with an extended postpartum anestrous interval. Journal of Dairy Science 86:1876-1894. 
 74 
Rivest S, Lee S, Attardi B, Rivier C. 1993: The chronic intracerebroventricular infusion of interleukin-1 
beta alters the activity of the hypothalamic-pituitary-gonadal axis of cycling rats. I. Effect on LHRH 
and gonadotropin biosynthesis and secretion. Endocrinology 133:2424-2430. 
Roche JR, Dillon PG, Stockdale CR, Baumgard LH, VanBaale MJ. 2004: Relationships among 
international body condition scoring systems. Journal of Dairy Science 87:3076-3079. 
Roche JR, Macdonald KA, Webster J, Schuetz K, Matthews LR, Meier S, Loor JJ, Rogers A, Morgan S, 
Taukiri S, Verkerk GA. 2013: Calving body condition score affects indicators of health in grazing dairy 
cows. Journal of Dairy Science 96 (In press). 
Rukkwamsuk T, Wensing T, Kruip TAM. 1999: Relationship between triacylglycerol concentration in 
the liver and first ovulation in postpartum dairy cows. Theriogenology 51:1133-1142. 
Sagartz JW and Hardenbrook HJ. 1971: A clinical, bacteriologic, and histologic survey of infertile 
cows. Journal of the American Veterinary Medical Association 158:619. 
Sales K and Jabbour H. 2003: Cyclooxygenase enzymes and prostaglandins in pathology of the 
endometrium. Reproduction 126:559-567. 
Schams D and Berisha B. 2002: Steroids as local regulators of ovarian activity in domestic animals. 
Domestic Animal Endocrinology 23:53-65. 
Schisterman EF and Perkins N. 2007: Confidence intervals for the Youden index and corresponding 
optimal cut-point. Communications in Statistics - Simulation and Computation 36:549-563. 
Senosy WS, Uchiza M, Tameoka N, Izaike Y, Osawa T. 2009: Association between evaluation of the 
reproductive tract by various diagnostic tests and restoration of ovarian cyclicity in high-producing 
dairy cows. Theriogenology 72:1153-1162. 
Serhan CN, Ward PA, Gilroy DW. 2010. Fundamentals of inflammation. Pages 1-17. Cambridge 
University Press, New York. 
Sheldon I, Noakes D, Rycroft A, Pfeiffer D, Dobson H. 2002: Influence of uterine bacterial 
contamination after parturition on ovarian dominant follicle selection and follicle growth and 
function in cattle. Reproduction 123:837-845. 
Sheldon IM, Cronin J, Goetze L, Donofrio G, Schuberth H-J. 2009: Defining postpartum uterine disease 
and the mechanisms of infection and immunity in the female reproductive tract in cattle. Biology of 
Reproduction 81:1025-1032. 
 75 
Sheldon IM and Dobson H. 2004: Postpartum uterine health in cattle. Animal Reproduction Science 
82:295-306. 
Sheldon IM, Lewis GS, LeBlanc S, Gilbert RO. 2006: Defining postpartum uterine disease in cattle. 
Theriogenology 65:1516-1530. 
Solomon EP, Berg LR, Martin DW. 2004. Biology. Pages 834-835. Thomson Brooks-Cole, Victoria, 
Australia. 
Sordillo LM, Contreras GA, Aitken SL. 2009: Metabolic factors affecting the inflammatory response of 
periparturient dairy cows. Animal Health Research Reviews 10:53-63. 
Soto P, Natzke RP, Hansen PJ. 2003: Actions of tumor necrosis factor-alpha on oocyte maturation and 
embryonic development in cattle. American Journal of Reproductive Immunology 50:380-388. 
Spicer LJ and Alpizar E. 1994: Effects of cytokines on FSH-induced estradiol production by bovine 
granulosa cells in vitro: Dependence on size of follicle. Domestic Animal Endocrinology 11:25-34. 
Taylor FGR, Brazil TJ, Hillyer MD. 2010. Diagnostic techniques in Equine medicine. 2nd ed. Pages 81-
88. Elsevier Health Sciences UK, China. 
Thatcher WW, Meyer MD, Danet-Desnoyers G. 1995: Maternal recognition of pregnancy. Journal of 
Reproduction and Fertility. Supplement 49:15-28. 
Thatcher WW and Wilcox CJ. 1973: Postpartum estrus as an indicator of reproductive status in the 
dairy cow. Journal of Dairy Science 56:608-610. 
Trevisi E and Bertoni G. 2008. Attenuation of acetylsalicylate treatments of inflammatory conditions 
in periparturient dairy cows. Pages 23-37. P. I. Quinn, ed. Nova Science Publishers, New York. 
Verkerk GA, Stevens J, McKay B. 2000. Management for sustainable reproduction. Pages 53-65 in 
Proc. Ruakura Farmers Conference. Ministry of Agriculture & Fisheries, Hamilton, New Zealand. 
von Krueger X and Heuwieser W. 2010: Effect of flunixin meglumine and carprofen on pregnancy 
rates in dairy cattle. Journal of Dairy Science 93:5140-5146. 
VSN-International. 2011. GenStat for Windows. 14th ed. VSN International, Hemel Hempstead, 
United Kingdom. 
Williams CY, Harris TG, Battaglia DF, Viguie´ C, Karsch FJ. 2001: Endotoxin inhibits pituitary 
responsiveness to gonadotropin-releasing hormone. Endocrinology 142:1915-1922. 
 76 
Williams EJ, Fischer DP, Noakes DE, England GC, Rycroft A, Dobson H, Sheldon IM. 2007: The 
relationship between uterine pathogen growth density and ovarian function in the postpartum dairy 
cow. Theriogenology 68:549-559. 
Williams EJ, Fischer DP, Pfeiffer DU, England GCW, Noakes DE, Dobson H, Sheldon IM. 2005: Clinical 
evaluation of postpartum vaginal mucus reflects uterine bacterial infection and the immune 
response in cattle. Theriogenology 63:102-117. 
Wu G. 2009: Amino acids: metabolism, functions, and nutrition. Amino Acids 37:1-17. 
Zamet CN, Colenbrander VF, Erb RE, Callahan CJ, Chew BP, Moeller NJ. 1979: Variables associated 
with peripartum traits in dairy cows. II. Interrelationships among disorders and their effects on intake 
of feed and on reproductive efficiency. Theriogenology 11:245-260. 
 
 
